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Abstract
Skeletal tissue has a good ability to self-regenerate after injury through the processes
of bone healing. However, bone can suffer from a wide range of pathologies, cancers
or congenital defects which lead to loss of bone mass and density.
Current progresses in tissue engineering have shown great potential for creating bi-
ological alternatives and new perspectives for the treatment of bone damage and
defects. In this approach, scaffolding plays a pivotal role. In particular, the prin-
ciples of biomimesis have to be followed and the scaffolds have to be designed to
this purpose. Furthermore, these tissue engineered systems have not only to sup-
port and guide the new tissue formation, but they have to induce a complete tissue
functionality.
The aim of this research work was the application of these advanced principles to
produce and evaluate scaffolds for bone regeneration.
Starting from the idea to mimic the extracellular matrix (ECM), template that
characterizes the early step of the bone healing process, we design scaffolds for
the evaluation of biological outputs considering the initial ECM produced by cells.
We used two polymers, naturally (silk fibroin) or synthetically (poly-d,l-lactic acid)
derived, and we modulated scaffold geometry (random vs ordered pore distribution),
pore size and chemical composition, combining spongy and fibrous structures.
The scaffolds were indeed considered as models, to investigate if they control cell
production of type I collagen, principle component of the natural template for the
final mineralization. Moreover, due to the key role of vessel formation in tissue engi-
neering and the correlation between osteoblasts and endothelial cells, the influence
of the scaffolds on angiogenesis and vascularisation was assessed.
The innovation of this study consists in the evaluation shift from the final healing
stage to the earlier stages. In fact, the results emphasize the possibility to correlate
the scaffold morphology to type I collagen assembly, which in turn affects the final
mineralization process, allowing to evaluate the tissue produced by osteoblasts from
1
the first steps of bone formation. Moreover, we were able to control some cell
behaviours changing construct properties.
In a future research, a segmental bone defect models should be considered to better
characterize the role of scaffold features during bone healing process and to deter-
mine if it would be better to use scaffolds which favour angiogenesis or mineralization
to speed up a physiological bone regeneration process.
2
1 Introduction1
1.1 Extracellular matrix
The extracellular matrix (ECM) is the major component of the cellular microen-
vironment, or niche. The principal constituents of ECM are fibrous proteins with
a support function (i.e. collagens, fibronectin, laminins, vitronectin, elastin), other
specific proteins (i.e. growth factors, small matricellular proteins and small integrin-
binding glycoproteins), proteoglycans (PGs) and water. Physical, mechanical and
biochemical properties of tissues depend on the specific assembling and concentra-
tion of these constituents [3]. ECM undergoes to a continuous remodeling driven
by cells that cleave, rearrange and deposit the different components and define the
tissue architecture, with reciprocal interactions.
All cells are in connection with their ECM, either continuously or at certain stage
of their life, such as at stem or progenitor cell phase or during cell migration and
proliferation.
ECM most evident role is related to its scaffolding/template function for cells and
tissues. In fact it can guide and regulate cell activity (i.e. proliferation, adhesion,
migration, differentiation, apoptosis and gene expression) through patterned chem-
ical signals (ligands) properly exposed to cell receptor (transmembrane proteins) as
well as mechanical and structural stimuli [4].
The complex mechanism of ECM remodeling allows regulation of stem cell differ-
entiation and it is central during growth and wound healing. Moreover, anomalous
ECM dynamics generate a deregulation of cell activities, resulting in congenital de-
fects and causing pathological tissue growths (fibrosis and cancer). Understanding
and regulating the remodeling mechanisms of ECM is strategic for tissue engineering
and regenerative medicine perspectives [5].
1Part of this chapter has been submitted as a book chapter: Carletti, E., Stoppato, M., et al. The
functional role of Extra Cellular Matrix. Scaffolds for Tissue Engineering: Biological Design,
Materials and Fabrication.
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1.1.1 ECM functions
ECM defines the functional organ architecture while acting as bioactive substrate
for cell adhesion, migration, growth and differentiation. Moreover, ECM serves
as storage for molecules and growth factors, transmits and distributes the loads
preventing mechanical failure, partitions and distributes cells in specific functional
units [6].
The chemical composition, architecture, physical and mechanical properties of ECM
vary according to the tissues and their specific developmental stage, age, pathological
state and during the wound healing process.
1.1.2 Biochemical properties
ECM is typically a highly hydrated macromolecular network composed of various
amounts of proteins and proteoglycans.
All macromolecular components of the ECM are synthesized by cells and subse-
quently secreted in the extracellular space where further physical-chemical modifi-
cations can take place.
Nearly all of the proteins are glycoproteins [7], characterized by oligosaccharide
chains covalently attached. Most of them are fibrous structural proteins and include
the large family of collagens, laminins, fibronectins and nidogens. Elastin is also
a protein but without chains of carbohydrate residues attached. Proteoglycans are
other proteins but consist of big clusters of carbohydrate chains, glycosaminoglycans
(GAGs), attached to a core protein. Some examples are heparin sulphate (which
regulates a wide variety of biological activities, including developmental processes,
angiogenesis and blood coagulation), chondroitin sulphate (which is considered to
stabilize brain synapses), and keratin sulphates (which are involved in various tissues
development and wound healing). Among the GAGs, hyaluronic acid (HA) does
not have a protein component. HA has many functions: it stimulates cytokine
and angiogenesis, attracts water, influences damaged or growing tissues and allows
nutrients and metabolites diffusion. Moreover, particularly during embryogenesis,
hyaluronic acid creates cell-free space filled with water into which cells can proliferate
and migrate.
As a highly charged protein network, rich in polysaccharide modifications, the ECM
shows a wide variety of unique functions reflecting buffering, hydration, binding and
4
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force-resistance properties [8].
GAGs can bind to a myriad of growth factors and they can control the diffusive range
and accessibility of ligands to their receptors. Heparan sulphate proteoglycan, for
example, facilitates interactions between ligands and their receptors and has the
capability to bind to various growth factors [9].
ECM acts as a molecular “reservoir” binding to ligands and creating a concentration
gradient of many growth factors produced by cells, such as bone morphogenetic pro-
teins (BMPs), fibroblast growth factors (FGFs), hedgehogs (HHs), and Wnt proteins
(signaling molecules that control cell-cell communication) [10, 11].
It is widely recognized that the unique chemical composition of each tissue, due to
the mix of the components described, maintains biological and biochemical infor-
mation, guiding cells behavior and tissue organization.
1.1.3 Physical properties
The physical properties of ECM refer to its morphology (i.e. shape, structure, poros-
ity, pattern), topography (related to the surface), water content, and biomechanical
characteristics. ECM has a clear structural function, fundamental in connective tis-
sues, but still significant in all the other tissues where a support for cell is provided.
Some of the ECM proteins, such as collagens and elastin, are organized in fib-
rils/fibers forming the ECM skeletal structure and providing the tensile strength
and viscoelasticity of the tissue. The network solidity is instead guaranteed by
linking proteins, working as natural crosslinkers, including collagens, fibronectin,
laminin, and nidogen [3, 4, 11].
The most evident role of ECM is related to its scaffolding/template support func-
tion. More generally, ECM supports tissues structure, ensuring their integrity and
favoring cell anchorage and migration or, in the case of basement membrane, cre-
ating a barrier for cells and factors migration [4, 10, 12, 13, 14, 15]. The cell-ECM
constant interaction is fundamental to maintain the proper ECM composition and
assembling, which, in turn, can promote cell movement and orientation. It has
been demonstrated the importance of the ECM structure on the formation of tissue
during its healing process and, in particular, that the orientation of collagen fibrils
can significantly impact on cell arrangement and, consequently, on matrix formation
[16, 17].
ECM is a composite material which comprises a fibrous structural net (fibrillar and
5
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elastic proteins) embedded in a of porous hydrated gels matrix of glycosaminoglycans
(GAGs). The ratio between the constituents varies according to the tissue.
GAGs and proteoglycans can combine to form huge polymeric complexes, and they
are also connected with fibrous matrix proteins (i.e. collagen) and with protein
networks (i.e. basal lamina), creating a continuous complex fiber arrangement [18,
19, 20]. GAGs tend to arrange in a highly extended conformations that occupy a
large volume, forming gels even at low concentrations. The high density of negative
charges in the chain attracts cations, Na+, that are osmotically active, thus forcing a
large amounts of water into the matrix. This creates a swelling pressure, that enables
the matrix to withstand compressive forces (in contrast to collagen fibrils, which
resist stretching forces). As mentioned before, one of the main glycosaminoglycans
is the hyaluronic acid, also important for its resistance to compressive forces due to
its capacity to attract water. Chondroitin sulphate is another glycosaminoglycan
that contributes to the tensile strength of cartilage, tendons, ligaments and walls of
the blood vessels.
The ECM biomechanical behavior describes the reaction of ECM to loads, such as
compressive, tensile, bending, torsion and shear stresses applied by cells or external
forces [21]. These loads have a great impact on the ECM characteristics, influencing
its elasticity/rigidity. ECM mechanical properties range from those of soft and
compliant structures, as in adipose tissue, brain, or muscles, to those of stiff and rigid
tissues, as bones [22, 23]. Tissues clinical studies suggest that ECM elasticity plays a
significant role in organ homeostasis and function, recognizing that diseased tissues
have markedly altered elasticity compared to the healthy ones and that changes in
tissue stiffness may indicate a pathologic condition [24, 25]. Indeed, the extent of
tissue stiffness is often considered a good prognostic indicator for disease [8].
1.1.4 Mechanical transduction
It is widely accepted that mechanical stimuli have an important role in tissue-organ
development and physiological processes. In fact, cells and ECM have a dynamic
3D interrelationship that is kept in balance and influenced by internal and external
stimuli, to control cell phenotype and matrix maintenance process. Local mechanical
cross-talk between cells and the surrounding environment is described by Provenzano
et al. [26] as a unifying principle that connects ECM micro- and nano-scale structure
with cell shape, distribution and differentiation.
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Cells have indeed developed sophisticated mechanosensors and systems, such as fila-
ments, integrins and cytoskeleton, connecting cells with ECM. In this way, external
forces can modify nuclear architecture, chromatin organization and, consequently,
gene expression and cell differentiation [27, 28, 29].
This means that external mechanical stimuli are transduced to cells through the
ECM that they are connected to, then cells are able to convert sensed mechanical
stimuli into biochemical pathways leading to different cell activities.
Part of such bidirectional communication between ECM and cells, is a result of a di-
rect mechanical connection between fibrous protein in the ECM and cell cytoskeleton
via integrins. Integrin-mediated cell-ECM interactions promote the assembly of cy-
toskeletal and signaling molecule complexes at focal adhesion sites. These complexes
include Src-family members, focal adhesion kinase (FAK), phosphatidylinositol-3´-
kinase (PI3K), and phospholipase C (PLC) [30, 31]. Accordingly, cells do not only
exert forces, but also respond to the resistance sensed through cytoskeleton organi-
zation/tension, triggering several intracellular signaling pathways [32].
In coordination, it seems that there is a synergy between mechanical stimuli and
hormones, growth factors, and inflammatory mediators which collectively activate
the same signalling pathways [29, 30, 33, 34, 35].
During development, ECMs are able to adapt to the higher mechanical demands,
by increasing the size of the necessary tissue components [34, 36].
Furthermore, mechano-chemical transduction is altered in aging connective tissues.
In fact, recent evidence suggests that tension applied by cells to ECM is reduced or
lost during aging and diseases such as osteoarthritis [37]. The reduction observed is
similar to changes that occur as a result of disuse [38].
Mechanical transduction seems to be particularly important even during wound
healing. In this case, cells that are moving into a wounded area to synthesize new
ECM produce cellular contractile forces, and, simultaneously, in the final phases of
the process, the ECM tension transmitted through integrins can modulate cell fate,
removing the unneeded cells and organizing the new tissue.
7
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1.2 Bone composition and morphology
Bone is a dynamic and highly specialized form of connective tissue. The main
function of bone is to sustain and protect the soft tissues of the body, and it acts
as a storage facility for systemic mineral homeostasis. Bone tissue is characterized
by a unique composition which gives a marked rigidity and strength while still
maintaining a good degree of elasticity.
The bone structure consists of approximately 65-70%w mineral, 20-25% protein, 8-
9% water, and less than 1% cell amount [39]. Collagen constitutes approximately
95% of the organic matrix (which 99% is type I Collagen); the remaining 5% is
composed of proteoglycans and numerous non-collagenous proteins.
The major component of bone is, however, mineral. The main bone mineral com-
ponents are calcium phosphates, especially hydroxyapatite (Ca5(PO4)3(OH)). It
forms prism crystals, with a length of 20 nm and a thickness of 2 nm. The presence
of minerals combined with an appropriate distribution of collagen fibers in the ex-
tracellular matrix provides strong mechanical properties in terms of hardness, and
compressive, tensile, and torsion strength. From a material science perspective, it
is possible to describe the bone properties as if it was a composite material due to
its organic and inorganic components [40].
The relatively cell-free bone tissue comprises 4 different kinds of cells: osteoprogen-
itor cells, osteoblasts, osteocytes, and osteoclasts. Osteoprogenitor cells, deriving
from periosteum, present a high proliferative ability and are able to differentiate in
bone cells [41]. Osteoblasts tend to form sheets on the bone surface during tissue
formation and their role is to secrete the type I collagen and the non-collagenous
proteins, synthesizing and mineralizing new ECM. After the appropriate bone de-
position, osteoblasts decrease their metabolism and finally differentiate into osteo-
cytes. The osteocyte is the most abundant cell type of bone and is responsible for
its maintenance and remodeling [42]. These cells have the capacity not only to syn-
thesize, but also to resorb matrix to a limited extent. Each osteocyte occupies a
space, or lacunae, within the matrix. Instead, osteoclasts are large (100-200 μm),
multi-nucleated cells, developed from hemopoietic cells of the monocyte–macrophage
lineage, that resorb bone. Active osteoclasts exhibit a characteristic polarity with
nuclei typically locate in the part closer to the removed bone surface [43].
Bones can be classified as long bones (e.g. femur, tibia), short (e.g. carpal, tarsal),
and flat (e.g. cranium, irregular bones). The resulting structure of the skeleton
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is influenced heavily by the individual’s mechanical loading history, acting both as
constraints and as driving forces in its architecture [44, 45].
Figure 1.1: Bone morphology
Morphologically, there are two main types of bone: compact (cortical) and trabec-
ular (cancellous or spongy). In compact bone, densely packed collagen fibrils form
concentric lamellae, and the fibrils in adjacent lamellae run in perpendicular planes
as in plywood. Trabecular bone has a loosely organized, porous matrix. Differences
in the structural arrangements of the two bone types are related to their primary
functions: cortical bone, more solid, provides mechanical and protective functions
and trabecular bone, more porous, provides metabolic functions [39, 46].
Thanks to cell activity, bone tissue undergoes a continuous renewal in a delicate
equilibrium between synthesis and degradation of the extracellular matrix. Its
metabolism and regeneration are under the influence of a variety of molecules and
local factors, such as Insulin-like Growth Factor (IGF), Fibroblast Growth Factor
(FGF) and Bone Morphogenetic Protein (BMP).
There are two principal physiologic processes of bone production: intramembranous
and endochondral ossification. Intramembranous ossification is the direct laying
down of bone into the primitive connective tissue occurs during embryonic develop-
ment by the direct transformation of mesenchymal cells into osteoblasts. Endochon-
dral ossification provides a mechanism for the formation and growth of the skeleton
during growth of the individual and it involves cartilage as a precursor [47]. Both
require a solid base and a well-developed vascular supply for the modification and
mineralization of the extracellular matrix.
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1.2.1 Collagen
Collagen is the most abundant family of proteins constituting the extracellular ma-
trix in animals and it represents one third of the total protein in humans [48, 49, 50].
Collagens are the major structural elements of all connective tissues and they provide
stability and structural integrity of tissues and organs [51].
Collagen molecules form the characteristic fibrillar and micro-fibrillar networks con-
tributing to the basement membrane structure as well as other structures of the
extracellular matrix. If originally it was widely accepted that all collagens were
secreted by fibroblasts in connective tissue, in the last decade, the knowledge on
the collagen family increased considerably identifying that osteoblasts, numerous
epithelial cells and other cell type are able to produce certain types of collagens [52].
So far, 28 genetically distinct collagen types have been described in vertebrates
[53, 54, 55, 56]. The different collagen types are characterized by considerable
complexity and diversity in their structure, their splice variants, the presence of
additional, non-helical domains, their assembly and their function. Based on their
structure and supramolecular organization, they can be grouped in different fami-
lies. The most widespread family of collagens with about 90% of the total collagen
is represented by the fibril-forming collagens, comprising collagen types I, II, III, V,
and XI. These collagens are characterized by their ability to assemble into highly
orientated supramolecular aggregates with a characteristic suprastructure, with di-
ameters between 25 and 400 nm. Type I contributes to the structural backbone of
bone [57, 58] and it is the most abundant and best known.
The central feature of collagen is characterized by three parallel polypeptide chains
(which generally consists of two identical chains and an additional chain that differs
slightly in its chemical composition) arranged in a helical conformation. The amino
acid composition of collagen results in a repeating X-Y-Gly sequence, where X and
Y can be any amino acid (often proline and hydroxyproline) and Glycine is found
at almost every third residue.
Collagen, as other secreted protein, follows a standard biosynthesis pathway. Col-
lagen chains are synthesized as longer precursors called procollagens, delivered and
packaged within the Golgi apparatus into secretory vesicles and released into the
extracellular space, where they are finally assembled and cross-linked. The resul-
tant protein consists almost completely of a triple-stranded helix, which is 1.5 nm
in diameter and 300 nm long [52, 59].
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Figure 1.2: Representation of collagen assembly.
The importance of collagen is attributed to many of its essential characteristics, in-
cluding thermal stability, mechanical strength and the ability to interact with other
biomolecules and cells. These properties are derived from the triple-helix structure
with its interstrand hydrogen bonds, hydroxylation of Proline residues in the Y po-
sition and covalent crosslinking within the triple helices. The hierarchical nature of
collagen organization permits the assessment of its mechanical properties at differ-
ent levels of structural complexity, including the tropocollagen monomer, individual
collagen fibrils, and collagen fibers [50]. For example it was determined that the
fracture strength of a tropocollagen monomer is higher than that of a collagen fib-
ril, 11 Gpa versus 0.5 Gpa, probably due to the covalent bonds breakage necessary
in the first case. Another measure of the strength is through the quantification of
shear modulus, connected to the rigidity. Hydration of collagen fibrils reduced their
shear modulus significantly, whereas cross-linking increased their shear modulus.
It is significant that a certain level of cross-linking is favorable for the mechanical
properties of collagen fibrils, however, high cross-linking results in a brittle collagen
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fibrils structure, a general symptom of aging [60]. In fact, an excessive high crosslink
density does not permit a high energy dissipation during deformation and leads to
a dehydrated collagen that results strong but not tough [61].
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1.3 Bone healing
Bone healing is a process that combine certain aspects of skeletal development and
growth involving a complex interplay of cells, growth factors and extracellular ma-
trix. Conventionally the process is explained in four stages. In the early step, the
cellular inflammatory reaction is followed by fibrocartilage tissue production (soft
callus tissue). This is the natural fingerprint for the formation of hard callus, that
is physiologically replaced by the final bone, either cortical or trabecular, remodeled
and completed in an ultimate stage. During the repair process every newly formed
tissue evolves from the previous and the entire healing mechanism results from the
development of these overlapped stages [1, 62, 63, 64, 65, 66].
Figure 1.3: A representative series of images of the four-stage model of fracture
healing. Adapted from Schindeler et al.[1]
1.3.1 Stage 1: inflammation
A bone damage is typically associated with disruption of the local soft tissue in-
tegrity, causing the bleeding within the site and the development of a hematoma.
The initial phase of wound healing is non-specific and it is characterized by an up
regulation of inflammatory mediators. Degranulating platelets, macrophages and
inflammatory cells are recruited in the site of tissue injury to combat infection,
secrete cytokines and growth factors, and advance clotting into a fibrinous throm-
bus. Over time, endothelial cells produce new capillaries into the clot, which is
13
Chapter 1 Introduction
reorganized into granulation tissue. Macrophages, giant cells and other phagocytic
cells clear degenerated cells and other debris. This cellular response is coordinated
by the secretion of a range of cytokines and growth factors. The in situ scenery,
when an inflammation condition is present, is extremely complex and not only cells
and molecules are interested but also the ECM with its biophysical features and
geometrical characteristics [1, 62, 67, 68, 69, 70].
1.3.2 Stage 2: soft callus formation
Fractures are usually characterized by some level of mechanical instability. Ossifi-
cation is therefore preceded by a cartilaginous template, a soft callus, that provides
a semi-rigid support to the fracture. Chondrocytes and fibroblasts are the cells
responsible for the synthesis of the cartilaginous matrix, temporary plug between
the fractured fragments, that is subsequently replaced. Chondrocytes, derived from
mesenchymal progenitors, before going through apoptosis undergo hypertrophy and
mineralize the cartilaginous matrix. An important role is played by the growth
factors that guide fibroblast proliferation, chondrocyte behavior and regulate vas-
cular morphogenesis of larger vessels and collateral branches from existent vessels
[1, 62, 66].
1.3.3 Stage 3: hard callus formation
This stage is dominated on a cellular level by osteoblasts which differentiate from
osteoprogenitors in the presence of osteogenic factors. The progenitor cells originate
from many sources such as periosteum, bone marrow, vasculature and surrounding
local tissues. During this step osteoblasts produce the woven mineralized bone ma-
trix, starting in the stable areas of the soft callus. In order for bridging new hard
callus, the unstable soft callus is gradually removed, concomitant with revascular-
ization. The vasculature is a key point for formation of the hard callus because it
increases oxygen tension in the local region that seems necessary for progenitor cells
that develop into osteoblasts [1, 62, 66].
1.3.4 Stage 4: bone remodeling
This final stage is characterized by bone remodeling, a process where hard callus is
replaced and new cortical or trabecular bone is formed. The key cell type involved
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are osteoclasts which resorb the surface of the bone and osteoblasts, which secrete
new bone. In particular, osteoclasts pump acid and proteinases into the resorption
domain to demineralise the matrix and to degrade the organic components, such
as collagen. Contemporary, osteoblasts lay down new bone, and secrete cytokines
that influence osteoclast behavior and are responsible for the coordination of bone
formation and bone resorption. During this stage vascularization is sustained [1, 62,
66].
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1.4 Bone damage, degeneration and clinical
treatment
In general, bone has a good ability to self-regenerate. However, bone can suffer
from a wide range of disorders. Among all the disorders, fractures, which lead to
delayed or non-union defect, are common. When the critical size is exceeded, a
surgery procedure is required for complete recovery. Moreover, in the orthopedic
field, extensive bone reconstruction is needed in case of widespread loss, as resulting
by severe congenital malformations, trauma, hypoplasia, ischemic necrosis, primary
neoplastic lesions (osteosarcoma, benign bone tumors) or secondary (metastases).
Due to the aging of the population and the spread of these disorders, socioeconomic
considerations of possible treatments are a major concern [71].
Internal or external fixator are commonly used to provide bone transfer along the
defect, to support functions and finally to adjust the bone length and alignment.
However, the process rate is relative slow, leading to complications in prolonged
treatment, such as infections, contractures and edema.
Currently, bone-grafting plays a predominant role. The current gold standard for
bone graft is the autograft, which involves harvesting bone from the patient’s own
body. This strategy is commonly considered a safe solution in terms of compatibility
and immune response absence, but also uncomfortable for patient in which a second
surgery is needed. Furthermore, the graft availability may limit the application of
this technique.
Another strategy uses allograft bone, derived from humans and harvested from an
individual other than the one receiving the graft. When the defect size exceeds the
homologous donor possibility, allografts may be a good alternative. Anyway, several
studies have demonstrated how allograft transplantation results in poor and inade-
quate remodeling, reabsorption and revascularization, with problems concerning the
graft rejection and the risk of infections.
As alternative, the use of synthetic bone grafts has been explored, producing bone
graft substitutes made from ceramics or metals. They are used to provide a replica-
tion of the missing bone segment or joint, but poor integration, high probability of
infections and rejections can occur, as well as technical problems involving breakage,
friction wear and loosening, precluding their general use in orthopedic field.
All of these options, each having its own advantages and drawbacks, are still not
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able to provide an adequate replacement for full recovery of the patients. Therefore,
tissue engineering may result as a viable alternative with the progression in this field
[72, 73, 74].
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1.5 Tissue Engineering
In 1988, during a conference organized by the National Science Foundation, the
term tissue engineering (TE) was for the first time introduced and defined as the
“application of the principles and methods of engineering and life sciences in order
to understand the fundamental relationships between the structure and functions in
mammalian tissues (both normal and pathological) and to develop biological sub-
stitutes to restore, maintain and improve tissue functions” [75]. The idea of this
interdisciplinary field is to replace or regenerate tissues which have been compro-
mised by trauma or pathologies allowing cell growth and thus restoring the original
tissue.
The main approach consists in producing a functional tissue starting from a scaffold.
Scaffolds are three dimensional structures made of natural and/or artificial mate-
rials and populated by cells, before or after implantation. The chemical, physical
and biological properties of the scaffold have to be designed carefully, to guide the
tissue regeneration. To improve tissue development specific signals can be conju-
gated to the material to engineer the construct. These signals can be chemical (i.e.
growth factors) or mechanical (i.e. hydrostatic pressure or compressive stimulation)
and their aim is to help processes such as tissue morphogenesis, ECM functional
distribution throughout the scaffold and cell differentiation [75].
The main challenge of this strategy is to control the 3D tissue development in a
functional way. The achievement of this goal is dependent on many variables: the use
of a cell-free or a pre-seeded scaffold, the choice of the most appropriate cell source,
the material of the scaffold, the design of the morphological, chemical and physical
properties of the scaffold, the parameters of the in vitro culture, the concentration
of growth factors, and so on.
The strategy generally followed consists in mimicking characteristics and properties
of the biological system to be regenerated. This principle is well known as biomimet-
ics. After all these considerations, the complexity of the tissue engineering approach
appears evident.
Nevertheless, applications are today commercially available, for instance for skin
regeneration to heal burns or diabetic ulcers and many studies are currently in
progress in the field of cardiovascular, urologic, neurologic, orthopedic and muscular
diseases. Results remain indeed promising and more and more benefits will soon be
available for patients.
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1.5.1 Scaffolds
Nowadays the importance of the extracellular matrix structure is well known. For
this reason, in a TE perspective, considerable effort has been devoted to obtain 3D
functional scaffolds. It is in fact recognized how cells in conventional culture plates
do not retain normal behavior due to the lack of in vivo 3D environment.
Scaffolds should be designed to have a high reproducibility and appropriate char-
acteristics such as porosity, interconnected geometry, elasticity and chemical com-
position, giving the material the right degradable or resorbable rate [76, 77]. These
requirements make the production of artificial substrates very challenging.
A scaffold can be developed by modulating different properties which in turn deter-
mine its biocompatibility, defined exhaustively by Williams [78]: “Biocompatibility
refers to the ability of a biomaterial to perform its desired function with respect
to a medical therapy, without eliciting any undesirable local or systemic effects in
the recipient or beneficiary of that therapy, but generating the most appropriate
beneficial cellular or tissue response in that specific situation, and optimizing the
clinically relevant performance of that therapy”.
Scaffolds have mainly a structural role, supporting cell growth and allowing a cer-
tain scaffold integrity during tissue regeneration [77]. At the same time the scaffold
porosity should permit nutrient supply, waste removal, cell migration and vascular-
isation.
A growing variety of techniques have been developed to manipulate natural and
synthetic materials and, scaffold design, has become increasingly precise, from the
macro to the nanoscale level. This multi-scale approach of structural design allows
to control scaffold characteristics and it is considered especially important because
nature often derives properties from multi-scale or hierarchical structures.
Natural ECM is a fully hydrated matrix and for this reason wettability is a key
property to be taken into account [79]. Synthetic bulk materials with a hydrophilic
behavior are indeed better at mimicking the aqueous physiologic environment. Con-
sequently, hydrogels, networks of hydrophilic polymer chains, have been used as 3D
matrix materials [80, 81] even if lack of mechanical properties and cell binding motifs
are common drawbacks.
Another possibility extensively studied was to design scaffolds based on the char-
acteristic fiber conformation of ECM proteins. Nano and micro structured fibrous
constructs to support and guide cells have been produced, mimicking the physical
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structure of the extracellular matrix.
In addition to mimic the mechanical and morphological properties of the ECM,
scaffolds can also mimic some aspects of molecular recognition. A strategy con-
sists to mix natural molecules to the scaffold, either adding the ECM components
in an appropriate ratio while creating the synthetic polymer scaffold; or covalently
attaching the desired ECM protein/peptide or glycosaminoglycan to the backbone
polymer [82]; or impregnating an already created polymeric scaffold with an appro-
priate combination of ECM macromolecules [83, 77].
3D biomimetic scaffolds can be also obtained isolating the main constituents of the
ECM and using them after purification without further modifications. The idea is
to utilize decellularised and sterilized natural extracellular matrix with biomolecules
of the natural ECM maintaining the physiological information. This would help to
overcome the lack of cell recognition signals usually noticed using synthetic matrix.
In addition, the goal to mimic the complex structures and regulation processes
within the living tissue has been persecuted using scaffolds in coordination with more
complex co-culture systems and/or bioreactors, tools to analyze cellular interactions
in different biological and environmental conditions [84].
1.5.2 Materials
To fabricate a scaffold, several so-called biomaterials have been proposed and used:
polymers, metals, ceramics and composites.
For bone tissue engineering, the most commonly used materials are natural and
synthetic polymers, due to their degradation properties; while in some other bone
applications, ceramic materials (i.e. calcium phosphate, glass ceramic, chalk cal-
cium carbonate, coralline hydroxyapatite) are also used, especially combined with
polymers as composites, due to their mechanical properties.
Natural derived polymers are obtained by extraction from living organisms and
include agarose [85, 86], alginate [81, 87], chitosan, collagen, glycosaminoglycan
(GAG) [88], hyaluronic acid [89, 90, 91], silk fibroin [92, 93, 94, 95], and finally
starch [96, 97]. They possess usually a good interaction cell-material, low toxicity,
low chronic inflammatory response and an ideal environment for cell growth but
exhibit poor engineering properties and are characterized by a certain variability.
Moreover, the main problem is to understand which are the induced stimuli. In fact,
cell response may not be what expected or desired.
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Synthetic polymers, such as polycaprolactone (PCL) [98, 99], poly(glycolic acid)
(PGA) [100, 101], poly(lactic acid) (PLA), or their copolymers (i.e. PLGA poly(lactic-
co-glycolic acid) [102, 103, 104, 105] or PCLLA Poly(ε-caprolactone-co-lactide)), or
blends, are generally less biocompatible than the natural polymers and it is neces-
sary to evaluate the possible toxicity of the released monomers. On the other hand
they have high and tunable properties, they are easily processed and adapted and
the results are usually more reproducible.
1.5.3 Process techniques
Bioartificial scaffolds are porous, degradable structures fabricated from polymers.
They can be nets, sponges, sheets, gels, or highly complex structures with intri-
cate pores and channels, fabricated using materials processing technologies. The
fabrication techniques must provide the correct design for cell support, adhesion,
migration, proliferation, differentiation and subsequently ECM biosynthesis. The
commonly used techniques can be divided in two main categories; in the first case,
scaffolds are generated with a random structure, in the second category porous scaf-
folds are produced with predetermined design and architecture, normally using a
computer-assisted device and with the material deposited layer by layer.
SOLVENT CASTING/PARTICULATE LEACHING
To produce thin films, polymer solution is casted on a support until the volatile
solvent evaporates. This well exploited technique allows to obtain good film quality,
desired thickness, and uniformity controlling process parameters, such as solution
viscosity, chemistry of the solvent, and process conditions. Solvent casting is of-
ten used in combination with particulate leaching to obtained 3D porous scaffolds.
Porogen agents such as ammonium bicarbonate, glucose, and sodium chloride, are
added to the polymer solution and, after solvent evaporation, leached out.
FREEZE DRYING
This process is based on the competition between solute interfacial concentration
gradient and surface energy and consists in the solvent sublimation under proper
pressure and temperature conditions. By controlling parameters such as polymer
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concentration, quenching temperature and cooling rate it is possible to tune pore
size, distribution, and alignment as well as mechanical properties [106].
PHASE INVERSION
A polymer solution is cast in a proper support and a second, non-miscible solvent
is subsequently added. Under specific conditions, the solvent and the non-solvent
induce the solution to phase-separate, obtaining a porous scaffold. Important pa-
rameters are solution viscosity, polymer density, interfacial energy and mechanical
stirring. In tissue engineering, supercritical carbon dioxide is recently become an
attractive non-solvent due to its non-toxic properties [107, 108, 109].
ELECTROSPINNING
A high voltage is applied to a polymeric solution that is extruded from a needle. The
solution becomes charged, the electrostatic repulsion counteracts the surface tension
and a liquid jet is formed. The jet dries in flight and the resulting submicrometric
fibers are collected on the grounded collector. The main parameters which govern
this process are solution properties, electric field strength, distance between collec-
tor and needle, temperature and humidity. The final result is a nonwoven fibrous
structure in which fiber orientation, morphology, thickness, and mesh spacing can
be controlled [88, 110, 111, 112].
STEREOLITHOGRAPHY
A photopolymerizable polymer solution is cast, layer by layer, using a specific light
source (generally UV) to selectively polymerize it. When the structure is concluded,
the extra solution is washed away and it is cured. This technique shows some
limitations such as a low resolution and a limited availability of biocompatible pho-
topolymers.
SELECTIVE LASER SINTERING
A CO2 laser beam is used to activate a sinterization process of polymeric powder.
The temperature is increased locally, fusing polymer particle to each other. Also in
this case, scaffolds are built up layer by layer.
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3D PRINTING
3D printing use an additive process, where successive layers of material are laid down
in different shapes, using digital technology. The three-dimensional printing technol-
ogy was developed at the MIT [113]. Scaffolds were produced by stacking different
layers in which a binder solution was injected into selected areas of sequentially
deposited layers of powder [96, 114]. Another strategy, known as fused deposition
modeling, is based on the use of a micro-extruder, which deposits successive layers
of a polymer solution or a melt on a support substrate. The micro-extruder or the
substrate can move in the x-y-z directions at a proper speed directed by a computer-
controlled mechanism. Scaffolds geometry and properties depend on the viscosity
of the polymer melt or solution, pressure applied to the extruder, temperature, and
humidity [115].
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1.6 Bone tissue engineering
The limitations associated with clinical use of autografts and allografts continue to
drive efforts to develop bone graft substitutes using the principles of biomaterials
and tissue engineering.
As mentioned before, tissue engineering requires a scaffold with proper physical,
chemical and mechanical properties. In this contest, osteogenic, osteoconductive,
and osteoinductive properties have to be taken in considerations. Osteogenic refers
to the capacity of bone cells to contribute to develop bone tissue in the construct,
osteoconductive to the material capacity to guide the reparative growth of the nat-
ural bone, and osteoinductive to the property of encouraging undifferentiated cells
to become active osteoblasts.
Numerous types of synthetic scaffolds have been fabricated and investigated try-
ing to understand how different scaffold design variables can influence the biologic
response. Structural scaffolds with adequate mechanical properties must often be
surface modified or combined with bioactive components to achieve good biological
properties. In the last decade advances in biomaterial synthesis and characteriza-
tion have been exploited to create a multitude of possible choices for the selection
of scaffold materials.
Many researchers are focusing their attention among the many possible combina-
tions of growth factors, cells, and genes to promote bone tissue formation. In spite
of these impressive efforts, biomaterials that precisely control the survival, prolifera-
tion and fate of stem cell populations in vitro and in vivo are still not well developed.
Moreover, it is not completely clear how physical and morphological properties in-
teract with cells and tissues. Nevertheless it is nowadays recognized that a scaffold
for bone tissue engineering, to be attractive, has to be biomimetic and designed to
control cell behavior [72, 116, 117].
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1.7 Angiogenesis in tissue engineering
Engineered tissues of relevant sizes that exceed the diffusion limit (1-2 mm), require
a vascular network capable of supplying oxygen, nutrients, signaling molecules and
removing waste. Insufficient blood vessels cause a decrease of cell viability and func-
tion as well as tissue formation and ischemia, leading to the failure of the engineered
tissue [118, 119, 120]. For this reason, the growth and development of vessels in the
engineered constructs has become a major goal in tissue engineering.
New blood vessels are formed through two main processes:
• angiogenesis: new vessels sprout from pre-existing blood vessels or, in the case
of intussusception, the lumen of an existing blood vessel splits to form two
separate vessels;
• vasculogenesis: new blood vessels are formed by recruited endothelial cells
differentiated from endothelial progenitor cells (EPCs).
In order to develop and establish a functional vascularization, a variety of approaches
are currently used.
The use of scaffolds alone made with angiogenic biomaterials can be used to recruit
endogenous cells to vascularize the scaffold in situ. This is a simple, cost effective and
versatile method of inducing angiogenesis, exploiting the vascular response induced
by inflammation during scaffold implantation.
Decellularized scaffolds have been also used to provide a natural template for recre-
ating the vascular network.
Current approaches to therapeutic angiogenesis focus on the angiogenic growth fac-
tor released from biomaterial scaffolds, permitting a localized and sustained delivery
of these molecules. The challenge in this case consists in controlling the right deliv-
ery rate profile of more growth factors and in using the proper dose of each one of
them [121].
Scaffolds can be also used to deliver specific cells (i.e cells transfected with genes
that allow over-expression of angiogenic factors).
Another strategy focuses on scaffold prevascularization. In this case endothelial
cells can be seeded onto the scaffolds to create tube-like structure. Alternatively,
scaffolds can be implanted subcutaneously in vivo until they are vascularized and,
subsequently, relocated in the desired site. In both case anastomosis (the capacity of
the scaffold vasculature to connect to the host vasculature) is fundamental [121, 122].
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Figure 1.4: Neovascularization encompasses both angiogenesis and vasculogenesis.
Angiogenesis represents the classic paradigm for new vessel growth, as mature,
differentiated endothelial cells form sprouts from parental vessels. Vasculogenesis
involves participation of endothelial progenitor cells that, recruited, form new
blood vessels. Images adapted from Isner at al.[2].
In coordination to the creation of vascularized tissue, it is finally essential that the
formed vessels are functional and persist over time [119].
26
2 Research strategies and
objectives
2.1 Thesis rationale
In the previous chapter, the skeletal system and the key role of ECM were in-
troduced. Then, it was described with particular attention the leading strategies
employed today and the issues remained open in the field of bone healing and regen-
eration. Finally, the principles of tissue engineering were defined, focusing on how
their application can potentially overcome the limits of the current treatments for
bone defects.
The final objectives of the presented research work were the production and the
evaluation of scaffolds for bone regeneration.
Starting from the concept of biomimicry a multicomponent scaffold to regenerate
bone was design. We hypothesized to be more efficient to try mimicking the ECM
template that characterized the early step of the bone healing process, rather than
the final bone tissue. In this way the normal regeneration progression would be
supported by scaffolds able to support cells and to trigger their response in a phys-
iologic way. The reference ECM chosen was therefore the one present in the soft
callus and not the final mineralized matrix.
Contemporary, the research focused on the evaluation of the cell response to the
scaffold properties. We decided to modify scaffold features and to investigate care-
fully the type I collagen network production and assembling because it represents
the natural template for the final mineralization.
Moreover, due to the key role of vessel formation in TE and the correlation between
osteoblasts and endothelial cells, the influence of the scaffolds on angiogenesis and
vascularization was assessed.
For those reasons different scaffolds were proposed, modifying geometries, morpholo-
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gies and chemical compositions. The produced constructs were used as model to
understand the strict relation between cell behavior, scaffold properties and ECM
production/assembling.
In the next sections materials, structures and setups used are introduced and de-
scribed.
2.1.1 Scaffold fabrication
2.1.1.1 Materials
In this work scaffolds were produced using two polymers: one from synthetic origin,
poly-d,l-lactic acid (PdlLA), and one from natural origin, silk fibroin (SF).
PdlLA
Poly-d,l-lactic acid is a aliphatic polyester. This is a very interesting category of
synthetic polymer because of their good mechanical properties, tailorability and
controlled degradation rate [123, 124, 125]. Due to the chiral nature of lactic acid,
two stereoisomeric forms are possible and distinct polymers can be obtained: the
two stereoregular polymer PdLA, PlLA, and the PdlLA. Poly-l-lactide (PlLA) is
the product resulting from the ring-opening polymerization of l-lactide; it presents
a crystallinity of about 37% with glass transition temperature between 50°C and
80°C and fusion temperature between 180°C and 190°C. Poly-d-lactide (PdLA) is
analogous to PlLA but it is derived from polymerization of d-lactide. Poly-d,l-
lactide is the racemic polymer obtain from a mixture of d- and l-lactic acids; it has
an amorphous structure presenting a glass transition temperature at about 60°C.
Figure 2.1: The two stereoisomeric forms of lactic acid: PdLA and PlLA.
The degree of crystallinity strongly affects the water uptake and the degradation
kinetic; in fact, amorphous regions offer a better accessibility and mobility to water
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molecules and degradation occurs at higher rate. Differences in crystallinity also
influence the mechanical properties with semicrystalline materials characterized by
higher performance [126].
The material itself and its degradation products were studied to verify the biocom-
patibility and toxicity. Publications report good biocompatibility results, with only
some few inflammatory responses [127]. Among polyester family, PLA is very in-
teresting because it is soluble in many different solvents, it is easy to process in
different 3D structures and, depending on the process story, it degrades in 2 to 12
months [128].
Poly-d,l-lactic acid (PdlLA, type RESOMER® 207, MW= 252 kDa) was purchased
from Boehringer Ingelheim, Germany. The polymer was used without further pu-
rification. The two solvent used, dichloromethane (DCM) and dimethylformamide
(DMF), were obtained from BDH Chemicals (UK) and J.T.Baker (Holland), respec-
tively.
Silk fibroin
The term silk indicates the protein polymers synthesized by epithelial cells in special-
ized glands of Arachnids and some Lepidoptera. According to their animal origin,
silk proteins differ in composition and final configuration, but some general proper-
ties can be identified: their primary structure is usually simple and repetitive, while
the secondary structure is mostly β-sheet because of the predominance of amino
acids with a short lateral chain in hydrophobic domains. These domains allow the
Figure 2.2: Scanning electron micrograph of a partial degummed silk filament.
formation of a packed tertiary structure thanks to the establishment of hydrogen
bonds along protein chains. This assembly gives silk high resistance and resilience,
which are needed during the formation of cocoons or spider webs [129].
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Silk from Bombyx mori cocoons has been widely utilized as biomaterial. The fibers
have a diameter of 10-25 µm and consist of two inner filaments of fibroin coated
by a layer of sericin, which acts as a glue and represents 25-30% of the whole fiber
[130]. A fibroin molecule is made of two protein chains, a light chain (about 26
kDa) and a heavy chain (about 390 kDa) in a ratio 1:1. They are joined by disulfide
bonds between two cysteine amino acids and by a glycoprotein called P25 that is non-
covalently linked to both fibroin and sericin [129]. Amino acid composition of fibroin
from Bombyx mori consists mainly of glycine (43%), alanine (30%) and serine (12%).
The heavy chain is formed by 12 domains which compose the crystalline regions of
the silk fiber: they are repetitions of sequences Gly-X, where X can be one of the
following amino acids: alanine, serine, valine or threonine. As previously indicated,
the formation of crystalline structures is due to the short lateral chains of the amino
acids in these regions, which allow protein folding in a β-sheet conformation [131].
The secondary structure of the less crystalline portions of the heavy chain is random
coil because the bigger lateral chains, which cause a steric effect [129].
Figure 2.3: Typical amino acid sequence of fibroin.
Silk fibroin exists in two different polymorphisms: the glandular state before crys-
tallization (Silk I) and the state which follows its extrusion with the formation of
β-sheet secondary structures (Silk II). When fibroin is in a Silk I state, it is water sol-
uble and can be easily crystallized by heat or shear stresses. Fibroin can be in a Silk
I state also in the aqueous solution obtained in vitro. After crystallization, β-sheet
structures are asymmetric: one side is occupied by the hydrogen atoms of glycine
residues, while methyl groups of alanines populate the other side. Strong hydrogen
bonds and van der Waals forces form a structure which is thermodynamically stable
[129].
Degradation of fibroin is proteolytic and usually mediated by a foreign body re-
sponse. During degradation less crystalline regions of the protein are broken in
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peptides which can be phagocytized by cells more easily.
Biocompatibility of this natural polymer has been extensively established. It was
observed that silk sutures could elicit hypersensitivity in some cases, but it was
demonstrated that the major cause of these responses was sericin. Once sericin
is removed by degumming, the biological response of fibroin is comparable to all
biomaterials [129, 130].
In addition, silk fibroin has the nature of a multifunctional material which possesses
active domains in the linkers among hydrophobic blocks, which can be recognized
by cell receptors and demonstrated to stimulate cell adhesion and growth [132].
2.1.1.2 3D structures
Microfabricated scaffold
The microfabrication system, developed and optimized in our laboratories is able to
fabricate scaffolding supports of controlled geometry.
The microfabrication system consists of three independent slides (National Instru-
ment, Austin, Texas, US), that move a platform where the polymer solution is
extruded and the scaffold is built on. The extrusion system is composed by a glass
Figure 2.4: On the left the polymer extrusion from the metal micro-needle. On
the right typical microfabricated scaffolds.
syringe fixed up on an automatic pumping system (11 Plus, Harvard Apparatus,
Massachusetts, US) by which it is possible to set the proper flow rate; a metal
micro-needle (HamiltonTM, 34 gauge - 60 microns inner diameter; 1 cm length, 90º
point style) is connected to the glass syringe by a luer-lock mechanism.
The polymer solution is deposited from the needle of the glass syringe with a constant
flow rate on a polyethylene terephthalate (PET) platform. Scaffold is built on layer
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by layer in the vertical direction. Each layer is composed by a series of parallel
fibers, deposited by the syringe through a back-and-forward movement. The distance
between the fibers, which influences the properties of the scaffold, is a parameter
controlled with the software (LabVIEW). Once a layer is completed, the support
moves down, then, another layer is deposited, whose fibers are perpendicular to
those of the previous one.
Figure 2.5: Scanning electron microscopy images of PdlLA microfabricated scaf-
folds obtained changing polymer solution concentrations.
The process strongly depends on environmental variables (such as temperature and
humidity) and parameters such as number of layers, distance between fibers, pressure
applied to the syringe, viscosity of the solution, motor speed and dimensions of the
needle.
Some examples of PdlLA scaffolds obtained changing some parameters are reported
Fig. 2.5.
Sponge
Sponges are one of the most used scaffolds in bone Tissue Engineering, especially
because of their high porosity.
Several techniques can be employed, such as solvent casting particulate leaching
(with salt or glucose as porogen) and freeze-drying, which may be eventually com-
bined with gas foaming.
In particular, solvent casting particulate leaching, the technique selected, allows the
formation of a more interconnected porosity and a higher control on pore dimen-
sion. Briefly, porogen agents are added to the polymer solution and, after solvent
evaporation, leached out. In this work NaCl was selected as porogen and the poly-
mer was first dissolved in (70:30 v/v) dichloromethane/dimethylformamide solvent.
The final suspension of polymer solution and porogen was then dried under hood
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Figure 2.6: On the top scanning electron microscopy images of PdlLA sponges.
Scale bars = 100 µm. On the bottom micro-CT color-coded pore diameter scale
images. NaCl particulates with three different dimensional ranges were used: (A)
240-315 µm, (B) 315-425 µm, and (C) 425-1180 µm
overnight and washed into distilled water for 3 days to eliminate both the residual
solvent and the salt.
The obtained sponges were finally air dried at room temperature Setting the proper
combination of process parameters was very important to produce porous, well in-
terconnected and homogeneous scaffolds. Therefore, parameters such as polymer
concentration, NaCl amount and range size were optimized to obtained the specific
properties requested each times.
Images of sponges produced varying NaCl range size are shown in Fig. 2.6, while in
Fig. 2.7 there are some quantitative data obtained to characterize the same scaffolds.
In each chapter there are the specifications of the scaffolds produced.
Sponge with SF fibers
The fibers were obtained from Bombyx mori silkworm cocoons.
The idea was to use fibrous elements with active domains producing a scaffold more
similar to the natural ECM. Cocoons were boiled in two aqueous alkaline baths of
Na2CO3 (1.1 and 0.4 g/l, respectively), 1 hour each, in order to remove from the
fiber the external sericin coating and obtain fibroin. Degummed silk fibers were then
washed several times in distilled water and dried at room temperature. Then 0.05 g
33
Chapter 2 Research strategies and objectives
Figure 2.7: On the left porosity of the three scaffolds. On the right pore size profile
of the three scaffolds.
of these spread fibers was mixed with sieved NaCl particulates, ranging from 425 to
1180 µm as before, and the PdlLA solution (see chapter 2.1.1.2.2), obtaining a 1:14
w/w polymer/porogen final concentration. The mixture was air dried (24-36 hours)
and immersed in deionized water (dH2O) for 3 days with changes every 6 hours for
the removal of the porogen.
The parameters (PdlLA concentration, NaCl and SF fibers amount, porogen range
size) were chosen after several attempts, trying to optimize porosity and interconnec-
tivity. Images of scaffold with different PdlLA concentration and SF fibers amount
are shown in Fig. 2.8.
2.1.2 Cells
In this work three main type of cells were used: MG63, hMSC and HUVEC.
2.1.2.1 MG63
Human osteosarcoma-derived osteoblasts (MG63) are derived from malignant bone
tumor and have properties consistent with the characteristics of normal osteoblast
line. These osteoblast-like cells are often used as model of osteoblasts, especially in
studies testing biomaterials. Despite of gene expression profile has some differences
respect to primary osteoblast, MG63 are considered a good model due to the con-
stant properties they show. Moreover these cells, as osteoblast cells, express alkaline
phosphatase, osteocalcin and type I collagen.
34
2.1 Thesis rationale
Figure 2.8: Scanning electron microscopy images of PdlLA sponges with SF fibers.
The concentration of the initial polymer solution is different as the amount of the
SF fibers.
2.1.2.2 hMSC
Human mesenchymal stem cells (hMSC) are multipotent stromal cells with the
ability to differentiate into osteoblasts (bone cells), chondrocytes (cartilage cells),
adipocytes (fat cells) and neurons (nervous system cells). They were originally iden-
tified in the bone marrow stroma, where they regulate key stages of haematopoiesis.
MSCs have a great capacity for self-renewal while maintaining their multipotency.
The degree to which the culture will differentiate varies among individuals and how
differentiation is induced. The capacity of cells to proliferate and differentiate is
known to decrease with the age of the donor, as well as the time in culture.
2.1.2.3 HUVEC
Human umbilical vein endothelial cells (HUVECs) are cells isolated from the vein
of the umbilical cord. They therefore have the characteristics of venous endothelial
cells. They express specific venous markers and they also express all specific markers
of endothelial cells, whose surface antigens PECAM-1, CD144 and KDR, and vWF
factor, expressed in an intra-cytoplasmic manner. HUVECs are used as a laboratory
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model system for the study of the function and pathology of endothelial cells.
2.1.3 Animal model
A rat model in which each animal received four dorsal subcutaneous implants was
selected for its simplicity and its capability of responding by producing angiogenesis.
The experiment was performed at Georgia Institute of Technology (Atlanta, US),
under approval of the Georgia Institute of Technology Institutional Animal Care
and Use Committee. All animals were treated humanely per the guidelines outlined
in the Guide for the Care and Use of Laboratory Animals by the National Institutes
of Health (US).
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2.2 Outline and objectives
The skeletal system is unique in its capacity to regenerate after injury through the
processes of bone healing.
Factors that influence the repair process, particularly in situations of challenging
trauma or disease, include proper biological signals and sufficient vascularization.
The regenerative processes of osteogenesis and angiogenesis are strictly linked at
both cellular and molecular levels, and the responses of osteoblasts and endothelial
cells have been shown to be correlated in vitro.
Despite the knowledge on the bone healing, characterized by different steps, the
evaluation of the cell response at the first stages has not been deeply studied.
The overall objective of this work was therefore to investigate the role of scaffold
properties in osteogenesis and angiogenesis. The strategy was to design constructs
with the proper morphology and to evaluate the results focusing on the early step of
bone healing and not only on the final mineralization. This objective was evaluated
in the following specific aims.
CHAPTER 3 - AIM I
Determine the efficiency of different scaffold geometries exploring the relationship
among them and collagen 3D organization.
Two scaffolds, made with the same chemical composition but different 3D architec-
ture (a random versus a ordered structures), were used as model to verify different
influence on biological outputs. In particular the analysis of the collagen distribu-
tion was performed to evaluate if different morphology lead to different collagen
assembling and organization. The results show that scaffolds with random poros-
ity distribution seem to allow a collagen organization similar to the natural callus
matrix.
CHAPTER 4 - AIM II
Evaluate the effects of in vitro scaffold pore size on ECM matrix produced by MG63.
In this in vitro study we compared three different salt leached PdlLA scaffolds ob-
tained by varying the pore size range. This work is targeted to the intermediate stage
of bone healing and collagen I assembling evaluation was combined with gene expres-
sion measures of common genes involved in the osteogenesis. Results showed that
37
Chapter 2 Research strategies and objectives
pore size plays an important role in cell behavior and ECM development. Moreover,
a strict relation between collagen I assembly and mineralization was demonstrated.
CHAPTER 5 - AIM III
Evaluate angiogenic effects of SF fibers on a PdlLA engineered constructs.
The development of an extracellular matrix in most tissues, including bone, is depen-
dent upon the establishment of a well developed vascular supply to provide oxygen
and nutrients to regenerating tissues. We hypothesized that incorporation of silk
fibroin fibers to a PdlLA sponge enhances the construct capacity to better support
endothelial cell colonization in vitro and to promote in vivo vascularization.
CHAPTER 6 - AIM IV
Evaluate angiogenic and osteogenic response of hMSC in a co-culture model onto
different functionalized engineered constructs.
In vitro studies have shown that endothelial cells regulate the function of osteoblast
cells and vice versa. In this study we check the ability to support endothelial cells and
bone regeneration, testing two different scaffolds and two different setups: hMSC
and a co-culture of hMSC and HUVEC. The goal was to underline the influence of
endothelial cells and if the results are dependent on the scaffold properties.
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4 Influence of scaffold pore size
on type I collagen development:
a new in vitro evaluation
perspective1
4.1 Abstract
Bone tissue engineering takes part in the complex process of bone healing by com-
bining cells, chemical/physical signals and scaffolds with the scaffolds providing an
artificial ECM network. The role of the support template for cell activity is crucial
to guide the healing process. This in vitro study compared three different PdlLA
scaffolds obtained by varying the pore size generated by applying different salt leach-
ing processes. The influence of pore dimensions on the ECM matrix produced by
human osteosarcoma-derived osteoblasts (MG63 cell line) seeded on these differ-
ent materials was analyzed. This work is targeted on the intermediate stage of
the bone healing process, where a collagen network is beginning to develop by the
growing osteoblasts representing the template for the ultimate stage of bone forma-
tion. Imaging analyses assessed by confocal laser microscopy were combined with
gene expression measures of the most common genes involved in the bone healing
process. Furthermore, in vitro evaluations were carried out to investigate cell mor-
phology, proliferation and viability. Results showed that different pore size matrixes
can affect ECM development and that cell organization, collagen I assembly and
mineralization are strictly correlated.
1The work presented in this chapter was published in Journal of Bioactive and Compatible Poly-
mers as Stoppato M, et al., Influence of scaffold pore size on collagen I development: A new
in vitro evaluation perspective. Journal of Bioactive and Compatible Polymers (2013), 28(1),
16–32.
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4.2 Introduction
Tissue engineering for bone regeneration is based on developing scaffolds, which
are structural supports able to mimic the native tissue-like environment, and to
assist, once combined with cells, a complete healing process. The main idea is to
reproduce the natural Extracellulalar matrix (ECM) with scaffolds able to simulate
the physiological ECM features and to interact biomolecularly with cells tuning their
functions and guiding the entire multicellular events of ECM formation and tissue
regeneration [75, 169].
ECM of connective tissues is a fibrous composite that surrounds cells comprising
many biological components. It is the main component of bone combining inorganic
and organic parts. Osteoblasts are responsible for ECM synthesis and mineraliza-
tion. ECM components are central to every phase of wound healing. In the early
step, the cellular inflammatory reaction is followed by a fibrocartilage tissue pro-
duction (soft callus tissue). This is the natural fingerprint for the formation of hard
callus, that is physiologically substituted by the final bone, either cortical or trabec-
ular, remodeled and completed in an ultimate stage. During the repair process every
newly formed tissue evolves starting from the previous and the entire healing mech-
anism results from the development of these overlapped stages [1, 62, 63, 64, 65, 66].
Tissue engineering efforts to create functional biological tissues relies on 3D scaffolds
as temporary artificial ECM frameworks [170]. 3D constructs are currently produced
by different techniques using biocompatible polymers, either of synthetic or natural
origin. Different features can be achieved and have to be taken into account when
designing a scaffold for bone tissue reconstruction. Therefore, mechanical properties
and geometrical features (pore size, pore morphology and interconnectivity) should
be selected considering the mechanisms of biocompatibility described by Williams
[78, 171], that is the ability of a material to perform with an appropriate host
response during the regenerative phase.
In the present study, implications of scaffold geometry and collagen assembling on
the ultimate stage of mineralization of bone tissue were assessed. In a previous work
[16] a comparison between constructs with a regular ordered structures (microfab-
ricated scaffolds [144]) versus constructs with random morphologies (salt leached
sponges) was carried out to evaluate which architecture was more efficient as scaf-
fold to promote osteoblast-like cell activity. Particular attention was paid on the
collagen 3D organization, the natural template for the subsequent mineralization.
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The study demonstrated that a scaffold with a randomly organized structure, rather
than an ordered porous matrix, was more favorable as a template for a physiological
collagen assembly from a bone tissue regeneration perspective.
Based on this previous study and beginning with a salt leached scaffold morphol-
ogy from poly-d,l-lactic acid) (PdlLA) polymer [148, 163, 172], three different pore
size ranges were obtained by varying the porogen granulometry. The goal was to
develop an in vitro model to evaluate how different scaffold pore sizes can affect cell
behavior in terms of collagen I production, development, arrangement and mineral-
ization. A human osteosarcoma-derived osteoblast (MG63) cell line was used for a
preliminary in vitro biological evaluations [173]. Cell growth, distribution, prolifera-
tion and activity were studied. Imaging analysis by confocal laser microscopy, after
marking collagen I with a specific antibody, was combined with collagen quantifica-
tion as well as gene expression assessment by the reverse transcription quantitative
polymerase chain reaction (RT-qPCR) analyses. The expression of the most signifi-
cant osteogenic genes (RUNX2, Decorin and Alp) was evaluated [174]. AlizarinRed
staining was finally used to determine the degree of mineralization.
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4.3 Materials and Methods
Production of the salt-leached scaffolds
Sponges with randomly distributed pores were produced by solvent casting par-
ticulate leaching technique [126, 136, 150]. PdlLA (Resomer R207S, Boehringer
Ingelheim Germany) was dissolved in dichloromethane:dimethylformamide (70:30
v/v) to obtain a 7% (w/v) solution. Sieved NaCl particulates with three differ-
ent dimensional ranges (240-315 µm, construct S1; 315-425 µm, construct S2; and
425-1180 µm, construct S3) were mixed into the PdlLA, obtaining a 1:25 w/w poly-
mer/porogen final concentration. The mixture was air dried (24-36 hours) and
immersed in deionized water (dH2O) for 3 days with changes every 6 hours for the
removal of the porogen.
All the scaffolds were prepared with a thickness ranging from 2 up to 3 mm by
casting into glass petri dishes, then, once detached, they were cut into discs with
6 mm diameter. Before use in in vitro cell culture studies, scaffolds were sterilized
with aqueous ethanol solution 70% (v/v) at 4°C for 24 hours and dried under a
sterile hood at room temperature. Scaffold modifications due to the sterilization
process were not detected.
Scaffold characterization
Scanning electron microscopy (Supra 40 Zeiss, operating mode: high vacuum, sec-
ondary electron detector) was used for the evaluation of scaffold surface morpholo-
gies. Samples were previously sputter-coated with a thin gold layer under argon
atmosphere (SEM Coating Unit PS3, Assing S.p.A., Rome, Italy).
Scaffold pore size ranges were estimated by SEM imaging analyses using ImageJ
software. Three different scaffolds of each type (S1, S2 and S3) were analyzed and
a total of 150 pores per sample were considered.
Sponge porosity was assessed by a liquid displacement method similar to a previously
described technique [161, 162, 163]. Briefly, scaffolds were immersed into a 5 ml
graduated cylinder containing a known volume of ethanol (V 1). After evacuation of
the air from the pores and ethanol penetration into them the volume of ethanol was
recorded as V2. The ethanol-impregnated scaffold was taken from the cylinder and
the remaining ethanol volume was measured as V3. The scaffold porosity was given
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by the formula
p = V1−V3
V2−V3
.
The measures of porosities resulted from a triplicate analysis.
In vitro cell culture
After sterilization, scaffolds were placed in 96-well plates and washed several times
with sterile, distilled water. Samples were seeded with 20 μl media containing 5·104
cells, human osteosarcoma-derived osteoblasts (MG63 cells). After 1.5 hours media
were added and after 24 hours, scaffolds were moved from the original well plate
to a new one and incubated for a total of 28 days. Results were evaluated at
six experimental time points: 2, 5, 9, 14, 20 and 28 days. Minimum essential
medium (MEM) supplemented with 10% Fetal Bovine Serum (FBS), 1% Penicillin,
1% Glutamax, 1% Vitamin, 1% non-essential amino acids comprised the culture
medium. The culture medium was further supplemented with ascorbic acid (50
μg/ml) and 10 mM ß-glycerophosphate after nine days. Cells were incubated at
37ºC in a 5% CO2 atmosphere incubator, with medium changes every 2-3 days.
Proliferation
Cell number and its variations during the culturing time was measured through
the DNA quantification, using the PicoGreen assay (Quant-iT PicoGreen dsDNA
Assay Kit, Invitrogen). At predetermined time points the medium was removed
from wells and the scaffolds washed with PBS. 500 μl of 0.05% Triton-X was used
to completely cover the scaffold before freezing and storing at -20°C until analysis.
Each thawed sample was then sonicated for 10 seconds using a tip of an ultrasonic
processor (UP400S Hielscher Germany). Samples were aliquoted in triplicate (100
μl each) into a 96 Nunclon delta black microwell and 100 μl of PicoGreen working
solution was added to each well. Fluorescence was read by a spectrophotometer
(excitation wavelength: 485 nm, emission wavelength: 538 nm, Tecan Infinite M200
Pro, Switzerland). To correlate fluorescence to DNA concentration, a calibration
curve was generated using DNA standards at a known concentration, provided with
the assay. The DNA amount of each sample was divided by 7.7 pg of DNA, the
average amount of DNA in a human cell according to literature [175], to finally
obtain the cell number.
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Cell viability
The cellular metabolic activity was measured using alamarBlue assay kit (Biosource
International Inc., USA) at each culturing time. AlamarBlue is reduced by metabol-
ically active cells. The assay was performed according to the manufacturer’s instruc-
tions. In brief, the seeded scaffolds were incubated for 3 hours at 37°C with fresh
culture medium (with reduced serum) supplemented with alamarBlue diluted, sim-
ply adding the alamarBlue reagent as 10% of the sample volume. The references
were taken from wells with unseeded scaffolds, also incubated with the alamarBlue
solution. The resulting fluorescence was read on a fluorescence spectrophotometer
(excitation wavelength: 565 nm; emission wavelength: 595 nm, Tecan Infinite M200
Pro, Switzerland).
In addition, to visualize viable cells, they were stained with CalceinAM (Invitrogen
C3099). According to the manufacturer’s instructions, cells were incubated with
medium containing 0.1 mM of the reagent for 15 min and then examined by confocal
laser microscopy system (Nikon Eclipse, Ti-E).
Cell morphology and distribution, collagen I fibers assembling
Cell attachment, growth, distribution and migration as well as collagen I fiber for-
mation were detected using specific stainings and visualized by confocal laser mi-
croscope (Nikon Eclipse, Ti-E). The surface figures result from stacking multiple
horizontal images corresponding to different focused planes.
Cell growth and distribution were visualized by Oregon Green 488 phailloidin (Biosource
International, Invitrogen) and DAPI (Sigma Aldrich) staining. To detect collagen I
a primary rabbit antibody to human type I collagen was used (Meridian Life Science,
Saco, ME, USA). Briefly, fixation with a formaldehyde solution (4% formaldehyde in
PBS solution) was performed. After rinses with PBS, samples were incubated with
the primary antibody (in PBS containing 1% bovine serum albumin, BSA) overnight
at 4°C. The seeded scaffolds were then rinsed with PBS/BSA and incubated with
Alexa Fluor 546 goat anti-rabbit secondary antibody (Biosource International, In-
vitrogen) for 1.5 h at room temperature. Cells were permeabilized with TritonX
(0.2% TritonX in PBS solution) and stained with Oregon Green 488 phailloidin and
DAPI, according to the manufacturer’s protocol. After the final rinses with PBS,
samples were examined by confocal microscopy.
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Collagen quantification
The Sircol Collagen Assay kit (Biocolor Ltd., Belfast, United Kingdom) was used
to analyze the amount of collagen produced by MG63, according to the manufac-
turer’s instructions. Briefly, scaffolds were incubated overnight at 4°C in pepsin (0.1
mg/ml 0.5 M acetic acid) to obtain the collagen into solution. Sircol Dye Reagent
was added and mixed for 30 minutes. The collagen–dye complex was precipitated
by centrifugation, washed with ice-cold Acid-Salt Wash Reagent, centrifuged and
drained. Finally, Alkali Reagent was added to recover the dye and 200 μl of each
sample were transferred to a 96 micro well plate. The absorbance at 555 nm was
measured by a microplate reader (Tecan Infinite M200 Pro, Switzerland).
ECM mineralization
ECMmineralization was viewed after specific staining, AlizarinRed (Sigma Aldrich),
by a stereo microscope (Leica Wild M3Z Stereozoom Microscope). Samples were
washed with PBS and fixed in a 99% methanol solution at room temperature for
10 min. The seeded constructs were then washed with dH2O prior to addition of
750 µl of 1% AlizarinRed in 1/100 diluted ammonia per well and incubated at room
temperature for 3 min. Samples were washed with dH2O, dried at room temperature
and visualized by stereo microscopy.
RNA isolation and RT-qPCR
Total RNA was extracted using the RNeasy MINI kit (Qiagen) according to the man-
ufacturer’s instructions. Briefly, at each experimental time, scaffolds were minced
and put in a QIAshredder column with 600 μl of lysis buffer, then centrifuged. 600
μl of ethanol were added to the lysate and the solution was transferred in a spin
column. After centrifugation and discard of the flow-through, different buffers were
added and each time the columns were centrifuged.
The total RNA was eluted in 30 μl of RNase-free water. At each culturing time
the RNA was extracted from three constructs of the same scaffold type. The total
RNA was quantified using spectrophotometry (Nanodrop, Thermo Scientific) and
ranged from 400 ng to 5 μg with an average of 2 μg total RNA. The quality of the
RNA, expressed as RNA integrity number (RIN), was checked for randomly selected
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samples by automated electrophoresis (Bioanalyser 2100, Agilent) and ranged from
6.0 to 9.9 with a median of 8.6.
Reverse transcriptase–quantitative polymerase chain reaction (RT-qPCR) was per-
formed according to the protocol from the iScript cDNA synthesis kit (BioRad). In
brief, a reaction mixture consisting of 1× iScript Reaction Mix, 1 μl iScript Reverse
Transcriptase, 400-500 ng total RNA, and nuclease-free water was prepared in 20
μl of total volume. The single-strand cDNA synthesis occurred by incubating the
complete reaction mixture 5 min at 25°C, followed by 30 min at 42°C, and termi-
nated by incubation at 85°C for 5 min. Subsequently, the cDNA was diluted with
nuclease-free water to 2.5 ng/μl cDNA.
All qPCRs were performed in a 10 μl reaction volume containing 5 ng template
cDNA (2 μl), 2× SYBR FAST qPCR Master Mix Universal (5 μl) (KAPA) and
300 nM forward and reverse primers (Eurofins MWG Operon, Germany). Primer
sequences are listed in Tab. 4.1.
All reactions were carried out in duplicates in 96-well plates (Hard-Shell Low-Profile
96-Well Skirted PCR plates, Bio-Rad) on the CFX96 real-time PCR detection sys-
tem (Bio-Rad), followed by a regression Cq value determination method. The cycling
conditions comprised 2 min polymerase activation at 95°C and 40 cycles at 95°C for
10 sec, 60°C for 30 sec and 72°C for 10 sec, followed by a dissociation curve analysis
from 65 to 95°C. PCR efficiencies were calculated using a relative standard curve
derived from a cDNA mixture of 5 randomly selected samples (a ten-fold dilution
series with four measuring points).
Calculation of normalized relative expression levels was done in Excel as described
by Hellemans [176]. Normalization was performed using the SDHA reference gene.
Table 4.1: Sequences of qPCR primers
64
4.3 Materials and Methods
Statistical analysis
The data are expressed as mean ± standard deviation (mean ± SD). Statistic anal-
yses were performed using a statistical software (Prism 5, GraphPad Software). To
determine the statistical significance of differences among the results two-way or
one-way ANOVA test was performed (if the interaction term was significant). F-
test of the equality of the variances was conducted with a significance level of 0.05.
Significance was assigned at p-values less than 0.05.
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4.4 Results
Scaffold morphology
Porogen granulometry is one of the salt leaching process variables in which it is
possible to modify the final scaffold structure. By varying this parameter matrix
pore size variations can be obtained. Fig. 4.1 shows morphology of the scaffolds
selected for this study (indicated with S1, S2 and S3, inherently with an increase of
NaCl crystal size).
Figure 4.1: Scanning electron microscopy images of PdlLA scaffolds. Sieved NaCl
particulates with three different dimensional ranges were used: (S1) 240-315 µm,
(S2) 315-425 µm, and (S3) 425-1180 µm. Scale bars = 100 µm.
The pores were highly interconnected and randomly distributed in each scaffold. In
general, scaffold architectures were very similar with only variation in pore size, in-
creasing with the varying NaCl crystal sizes used in the different sponges. Through
imaging analysis it was found that scaffold pore size range were different on ana-
lyzed samples: between nanometers up to 275 µm in S1, nanometers and 325 µm
in S2, nanometers and 420 µm in S3. However, the scaffolds open porosity, calcu-
lated by liquid displacement method, was comparable and ranges from 85% to 88%
(S1=87±2%, S2=88±4%, and S3=85±2%).
Cell proliferation, viability, and distribution
Biological evaluations were performed at predetermined time points after seeding
osteoblast-like cells on the three different salt leached sponges.
Fig. 4.2A shows the cell proliferation trend, obtained by DNA content measurements.
Cells on all of the scaffolds increased rapidly in cell number up to 9 days, followed
by a more constant trend. Furthermore, S2 and S3 had a significantly higher prolif-
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eration compared to S1. Cell viability was determined during the cell culture period
using alamarBlue assay (Fig. 4.2B). The highest metabolic activity was reached after
day 9, when the osteogenic medium was added.
Figure 4.2: (A) Cellular proliferation of MG63 on PdlLA scaffolds. (B) Viability
for MG63 cell culture on PdlLA scaffolds. t, p < 0.05 vs the same scaffold at the
previous time point; *, p < 0.05 vs S1 at the same time point; ^, p < 0.05 vs S2
at the same time point.
By normalizing the metabolic activity per cell number (data not shown) it was
found that single cell viability was higher at day 2 and 5, during cell proliferation
and ECM production, and a further second smaller peak was evident at day 14,
after the addition of osteogenic medium.
These observations were further confirmed by CLM imaging analyses after staining
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the seeded scaffold with CalceinAM. Cell attachment, proliferation and viability are
shown in Fig. 4.3.
Figure 4.3: Confocal Laser Scanning Microscopy images of MG63 cells stained with
CalceinAM. S1, S2 and S3 at 2, 9 and 28 days after cell seeding are shown. Scale
bars = 100 µm.
In all samples proliferation and cell migration increased with incubation time. Pore
sizes were large enough to permit cells to invade the matrix and sponge surface
geometry acted as a template for cell distribution. At early time points scaffolds
showed single, unorganized cells. At later time points, cells started to interact
(Fig. 4.3) and to create a connected network. On S1, cells appeared less spread out
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and always in lower numbers. Cell morphology and distribution among the PdlLA
scaffolds were evaluated after staining with DAPI and Oregon Green 488 phailloidin
(Fig. 4.4).
Cells attached on all the constructs. On scaffolds S2 and S3, cells showed a more
developed and spread out cytoskeleton compared with S1 where they were more
isolated and had primarily spherical shapes.
Figure 4.4: Confocal Laser Scanning Microscopy images of MG63 cells stained with
Dapi and Oregon Green 488 Phalloidin. S1, S2 and S3 at 2, 9 and 28 days after
cell seeding are shown. Scale bars = 100 µm.
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Gene expression, collagen production, assembling, and
mineralization
Collagen amount as well as collagen I gene expression were quantified and further
characterized by imaging analyses. The amount of collagen over the culture time was
almost constant (Fig. 4.5A) with a higher collagen amount on S3 and S2 compared
to S1 at day 14 and 28.
Figure 4.5: (A) Collagen amount in the three scaffolds at the different time points
(B) Quantitative PCR analysis of Collagen I gene expression in cells cultured into
the three scaffolds at the different time points. t, p < 0.05 vs the same scaffold
at the previous time point; *, p < 0.05 vs S1 at the same time point; ^, p < 0.05
vs S2 at the same time point.
The high values at day 20 were not statistically significative.
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Quantitative analyses (Fig. 4.5B) showed that at day 5 collagen I gene expression
exhibited a consistent up-regulation for all samples. Afterwards, the expression
decreased. Collagen I gene expression did not show significant differences between
the three constructs, but at day 5, cells on S3 had a higher gene expression compared
to cells on the other two scaffolds. These results were validated by CLM images after
staining collagen I with a specific antibody.
Figure 4.6: Confocal Laser Scanning Microscopy images of the three constructs
(S1, S2 and S3) stained with a specific antibody for collagen I. Images of 2, 9, 20
and 28 days after cell seeding are reported. Scale bars = 100 µm.
Fig. 4.6 shows the increases in the collagen I with increased culture time that induced
a higher three dimensional organization (every image is the result of a maximum
intensity projection of a 3D stack). Collagen structures at early time points appeared
unorganized and quite similar on the three different scaffolds. Differences were
clearly visible from day 14, when a more complex collagen organization could be
observed in S2 and S3. In fact, on scaffold S1, a fiber-like collagen network was
detectable only at day 28, while for S2 and S3, a clear fibrous structure was already
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visible from day 14 and 21. At the same time it was apparent that the collagen
amount for S2 and S3 was higher than for S1. Gene expression of RUNX2 and
Decorin, two genes involved in osteogenesis, were also investigated (Fig. 4.7) [177,
178, 179, 180].
Figure 4.7: RT-qPCR analysis of RUNX2 (A) and Decorin (B) gene expression in
cells cultured into the three scaffolds at the different time points. t, p < 0.05 vs
the same scaffold at the previous time point.
In particular, RUNX2 is a well-known gene, downregulated during the differentiation
into mature osteoblasts which form mature bone. Downregulation of RUNX2 gene
was particularly evident for samples S2 and S3 after the addition of osteogenic
medium (after day 9), while on S1 this trend occurred earlier, between day 5 and
9. The changes in Decorin expression were significant. At day 20 in S2 and S3 a
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low value was shown and in the same constructs a subsequent rapid increase was
detectable. In constructs S2 and S3 between day 20 and 28, the expression of alkaline
phosphatase, an important osteogenic marker corresponding to calcium phosphate
deposition, was nearly doubled compared to S1 (data not shown).
To further assess these data and detect the presence of calcium phosphate, samples
were stained with AlizarinRed (Fig. 4.8). At day 28, S2 showed clearly visible red
spots while S3 continuous red lines. Few traces of mineralization were evident in S1.
Figure 4.8: Stereo microscopy images of the three constructs (S1, S2 and S3)
stained with AlizarinRed (calcium deposition stained red). Images of 5, 9, 20,
and 28 days after cell seeding are reported. Arrows indicate calcium deposition.
Scale bars = 500 µm.
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4.5 Discussion
The key to understanding the mechanisms of biocompatibility, as defined byWilliams
[78, 171], is the determination of which material variables influence the host response,
throughout the regenerative process. Unique combinations of chemical, biochemi-
cal, physiological, physical or other characteristics can influence how contact and
interaction between biomaterials and the cells or the tissues occur.
The role of scaffold morphology and its features as a bioactive template for cell
activities, targeted to regenerate damaged tissues, is therefore one of the main sub-
jects of tissue engineering research. Scaffolds should guide cell functions creating
a temporary matrix until the biological ECM produced is mature enough to sub-
stitute for the artificial structures. Therefore, different scaffold parameters should
be considered in designing a suitable matrix for cell support because every tissue
and/or cell type requires a scaffold with specific morphological and physical char-
acteristics [181]. Among the several characteristics that have to be considered, it
has been shown that larger porosity and pore size increase the ability of a scaffold
to be penetrated by cells and subsequently vascularized [95, 182], but, conversely,
its mechanical properties are lower. The best balance between these properties has
to be chosen, also considering the material, its degradation profile and the final site
of interest [41, 183]. The minimum recommended pore size in order for osteoblasts
migration into a scaffold has been shown to be 100 µm [184]. In addition, numerous
studies have shown better osteogenesis in implants with pores larger than 300 µm
[185, 186, 187].
In this study, targeted at bone tissue regeneration, the attention was focused on un-
derstanding how a single scaffold variable, pore size, can influence MG63 activity, in
particular regarding ECM development. Three PdlLA salt leached sponges were gen-
erated using diverse salt granulometries, resulting in scaffolds having a similar open
porosity but different pore size ranges. Scaffolds show a pore size ranging between
nanometers up to 275 µm (S1), 325 µm (S2) and 420 µm (S3). Such a broad pore
size distribution is suitable for bone regeneration allowing cells penetration, vessel
growth, nutrient transport and waste removal. An innovative approach to evaluate
the influence of scaffold morphology on the MG63 activity was used, accordingly,
ECM production and its development were considered with respect to the scaffold
pore size. The major goal of the work was to use the developed scaffolds differing
in pore structures as in vitro models to look at the mechanism of ECM formation
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in the early stage of regenerative process. All the phases of bone development were
characterized examining the expression of different genes. Among them, collagen
I, the main structural protein involved in the early stage of bone regeneration, was
analyzed quantitatively, via gene expression analysis, and qualitatively, via imaging
analysis.
An increased proliferation and a higher level of cell organization were found for
sample S2 and S3, when compared to scaffold S1, by DNA quantification and con-
focal laser microscopy evaluations (Fig. 4.2, Fig. 4.3 and Fig. 4.4). A reasonably
more difficult cell migration into the smaller pores may be an explanation of these
differences.
Gene expression of collagen I assessed by RT-qPCR analyses showed an up-regulation
at day 5 (Figure 5B). These results agree with early steps in bone healing: ECM
matrix begins to be produced usually during the first stage of bone formation cor-
responding in an up-regulation of the Type I collagen. Collagen I gene expression
is also linked to the osteogenic gene expression of RUNX2, essential for osteoblasts
differentiation and bone formation. It has been shown that RUNX2 is a positive
regulator that can up-regulate the expression of bone matrix protein genes such
as collagen I [179]. Furthermore, down-regulation of RUNX2 promotes osteoblasts
maturation. Considering the gene expression profile (Fig. 4.7) and the confocal im-
ages (Fig. 4.6) we can assume that cells on scaffold S1 matured prematurely around
day 9 without producing the right amount of organized collagen I necessary for ECM
development. Conversely, on S2 and S3, RUNX2 is down regulated later, allowing a
functional collagen I production and assembling. Furthermore, Decorin downregula-
tion is connected to collagen I assembling [178] and its increase for S2 and S3 at day
28 may represent that cells were not organizing collagen I anymore but they were
mineralizing the ECM already synthesized. A further evidence of these findings was
given by the up-regulation of the ALP gene only for sample S2 and S3 at day 28,
suggesting that only on these scaffolds the mineralization event was finalized. Those
RT-qPCR results are compatible with imaging analyses after Alizarin red staining
(Fig. 4.8) in which it was possible to notice mineralization trace only in S2 and S3.
Based on the results observed in Figures 6 and 8 it appears that S2 is characterized by
thicker collagen I fibers and calcified spots, S3 by a well-organized net of thin collagen
I fibers and slight lines of calcium while no clear mineralization is detectable on S1,
where collagen I seems less abundant and packed. This corroborates the connection
between the final mineralized bone and the previous phases of ECM developments,
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confirming the importance to evaluate each single phase of tissue formation.
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4.6 Conclusions
This in vitro study demonstrates that pore size plays an important role in cell
behaviour, focusing on ECM production and organization. In fact, a small pore size
appears to prevent an efficient cell migration and proliferation and, more interesting,
to induce MG63 to mature earlier without however producing a functional ECM.
Sponges with a pore size ranging up to 325 µm or to 420 µm lead instead to a well
organized collagen I network and to the subsequent calcium deposition. Moreover,
the evaluation of collagen I assembling could be a useful tool to predict the degree of
the final mineralization as regards the regenerative process. Indeed, this work results
interesting and innovative because it emphasizes the possibility to connect scaffold
morphology to collagen I assembly, which in turn affects the final mineralization
process, allowing to evaluate the tissue produced by osteoblasts from the first steps
in bone formation. Further investigations will consider the use of human primary
osteoblasts and results will be finally validates by in vivo studies.
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5 Effects of silk fibroin fiber
incorporation on mechanical
properties, endothelial cell
colonization and vascularization
of PdlLA scaffolds1
5.1 Abstract
Attainment of functional vascularization of engineered constructs is one of the fun-
damental challenges of tissue engineering. However, the development of an extracel-
lular matrix in most tissues, including bone, is dependent upon the establishment
of a well developed vascular supply. In this study a poly-d,l-lactic acid (PdlLA)
salt-leached sponge was modified by incorporation of silk fibroin fibers to create a
multicomponent scaffold, in an effort to better support endothelial cell colonization
and to promote in vivo vascularization. Scaffolds with and without silk fibroin fibers
were compared for microstructure, mechanical properties, ability to maintain cell
populations in vitro as well as to permit vascular ingrowth into acellular constructs
in vivo. We demonstrated that adding silk fibroin fibers to a PdlLA salt-leached
sponge enhanced scaffold properties and heightened its capacity to support endothe-
lial cells in vitro and to promote vascularization in vivo. Therefore refinement of
scaffold properties by inclusion of materials with beneficial attributes may promote
and shape cellular responses.
1The work presented in this chapter was published in Biomaterials as Stoppato M,
et al., Effects of silk fibroin fiber incorporation on mechanical properties, endothe-
lial cell colonization and vascularization of PdlLA scaffolds, Biomaterials (2013),
http://dx.doi.org/10.1016/j.biomaterials.2013.02.009
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5.2 Introduction
Tissue engineering aims to restore, regenerate or replace tissues functionally compro-
mised by injury or disease. The main strategy comprises scaffolds for tissue support
combined with cells or growth factors to exploit physical cues [118, 188, 189].
Use of engineered tissues is becoming commonplace in clinics for thin tissues and for
tissues characterized by limited metabolic demand (e.g. cornea [190], skin [191, 192],
cartilage [193, 194, 195]). For tissue engineering to be a viable treatment option for
more complex tissues, it is imperative that they can become vascularized. In fact the
lack of functional vascularization of the engineered constructs can be an indicator
of clinical failure [119, 196, 197, 198, 199, 200, 201].
Bone is a highly vascularized tissue. Physiologically, osteogenesis is preceded by
angiogenesis, the growth of new blood vessels from pre-existing vessels. It is therefore
important to achieve rapid development of an adequate blood supply, considering
the central role that the vasculature plays in tissue healing. Limited oxygen and
nutrient diffusion is associated with decreased cell growth and survival. Moreover,
the vasculature is involved in the production of growth factors, fundamental in the
recruitment, differentiation and behavior of cells that are crucial for bone formation
and bone healing [121, 202, 203, 204, 205].
To overcome these problems, two main strategies have been proposed to promote
vascularization of tissue constructs [119, 122, 202]. The first is scaffold-based and
takes advantage of biological [206, 207] or synthetic [208, 209, 210] scaffolds. In the
scaffold-based strategy, materials and structures determine biological outcomes. A
promising approach is biomimicry, a scientific design discipline that emulates natural
morphologies and architectures. The second strategy is cell-based and constitutes
two different approaches: one is to prevascularize the scaffold [95, 211, 212, 213, 214]
and the other is to promote angiogenesis in vivo [215]. The cell-based strategies in-
clude in vitro pre-vascularization, in which the constructs are seeded with endothelial
cells and in vivo pre-vascularization, where constructs are implanted into a primary
host to vascularize before implantation into the secondary host. Other cell based
approaches exploit the addition of growth factors (e.g. vascular endothelial growth
factor, fibroblast growth factor) [216, 217] or peptides derived from adhesion proteins
or extracellular matrix molecules (e.g. laminin, fibronectin, osteopontin) [218, 219]
or co-culture systems [182, 220, 221]. The challenge is always to promote tissue
healing and regeneration, while preventing ischemia and nutrient loss.
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The aim of this work was to refine a bone tissue engineering baseline scaffold, en-
hancing its capacity to support endothelial cells and to promote vascularization. In
recent years biomimesis, the mimicking of the architecture of the extracellular ma-
trix (ECM), has been a major approach explored for 3D scaffold development. The
ECM is a fibrous composite of nano and micro fibrils which surrounds cells and com-
prises many biological components. The biomimetic matrix should ideally provide
cell adhesion sites to maintain cell phenotype and function, mechanical strength,
a biodegradation rate compatible with tissue generation and a controlled degree of
inflammation [118, 211, 222, 223, 224]. In particular, biomaterial implants should
influence the host inflammatory and reparative response [68].
The idea to combine different structures and materials to produce multicomponent
scaffolds to improve the control of mechanical properties and metabolic cell activity
has been recently exploited. To satisfy these demands, among all the strategies,
multi-layered composite scaffolds, embed textile materials within hydrogels or bulk
polymers were proposed [225, 226].
In our study a multicomponent scaffold was developed, combining the properties
of a synthetic porous scaffold with the properties of a natural fibrous structure to
enhance bioactivity. Silk fibroin fibers were incorporated into salt-leached sponge
without modifying scaffold porosity. The baseline scaffold, composed of poly-d,l-
lactic acid (PdlLA), was specifically designed to promote ECM production and
mineralization providing a perfect 3D porous structure as support [16, 17]. Silk
fibroin fibers were selected for their ability to support endothelial cell attachment
and growth. Unger et al. demonstrated the capability of silk fibroin fibers to favor
the formation of microcapillary-like structures in vitro. The authors also reported
a rapid anastomosis of preformed capillaries with the host vasculature and a rapid
vasculature growth into the silk construct thus leading to the vascularization in vivo
[182, 221, 227]. Moreover silk fibroin fibers have been characterized by a gradual
degradation attributable to macrophages and multinucleated giant cells, which in
turn can produce pro-angiogenic molecules [223, 228]. Our hypothesis was that the
capacity of PdlLA sponge to support endothelial cells in vitro and to promote vas-
cularization in vivo could be improved by addition of silk fibroin fibers. In addition,
the properties of both scaffolds were investigated.
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5.3 Materials and Methods
Scaffold production
Two experimental groups were established; Group 1 (control scaffold) and Group 2
(scaffold with fibers).
Group 1 was produced by the solvent casting particulate leaching technique [126].
PdlLA (Resomer R207S, Boehringer Ingelheim, Germany) was dissolved in dichloromethane:
dimethylformamide (70:30 v/v) and a 7% (w/v) solution was prepared. Sieved NaCl
particulates, ranging from 425 to 1180 µm, were mixed with PdlLA, obtaining a 1:25
w/w polymer/porogen final concentration. The mixture was air dried (24-36 hours)
and immersed in deionized water (dH2O) for 3 days with changes every 6 hours for
the removal of the porogen.
In parallel, fibers were introduced into the scaffold (Group 2). The fibroin nets were
produced from Bombyx mori silkworm cocoons. Briefly, cocoons were degummed
by boiling twice, 1 hour each, in an aqueous solution of Na2CO3 (1.1 and 0.4 g/l,
respectively), in order to remove sericin. Degummed silk fibers were then washed
several times in distilled water and dried at room temperature. Then 0.05 g of
these spread fibers were mixed with sieved NaCl particulates, ranging from 425
to 1180 µm as before, and the PdlLA solution (as above), obtaining a 1:14 w/w
polymer/porogen final concentration. The mixture was air dried (24-36 hours) and
immersed in deionized water (dH2O) for 3 days with changes every 6 hours for the
removal of the porogen. Before use, scaffolds were cut into discs of 8 mm diameter,
sterilized with aqueous ethanol solution 70% (v/v) and dried under a sterile hood
at room temperature.
Scaffold characterization
Scanning electron microscopy (Supra 40, operating mode: high vacuum, secondary
electron detector, Carl Zeiss, Europe) was used for the evaluation of scaffold mor-
phologies. Samples were previously sputter-coated with a thin gold layer under
argon (SEM Coating Unit PS3, Assing S.p.A., Rome, Italy).
A micro-CT system (µCT 40, Scanco Medical, Bassersdorf, Switzerland) was used
to image and quantify the 3D microstructure of each sample as previously described
[229]. Briefly, the samples (n=4/group) were scanned at 12 µm voxel resolution with
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an integration time of 250 ms. Isotropic slice data were obtained and reconstructed
into 2D images. These slice images were compiled and analyzed to render 3D images
and obtain quantitative architectural parameters. Regions of interest were selected
in each slice image and thresholded to eliminate background noise. A threshold
to distinguish polymer material from pore space and background noise was chosen
and kept consistent throughout all evaluations. Porosity, pore size distribution and
degree of anisotropy were evaluated.
After measuring the cross-sectional area, wet scaffolds (n=4/group) soaked in PBS
for 30 minutes were mechanically tested. Compressive mechanical testing was per-
formed using a uniaxial electromechanical testing device (Info 650R, DDL, Eden
Prairie, MN). Initial scaffold height was measured using a micrometer. Samples
were tested to failure at a rate of 1 mm/minute. Standard solid compression plates
were used for testing. A preload of approximately 1N was applied to the samples
before initiating compression testing. Stress vs strain data were computed from load
and displacement measurements, and compressive modulus was determined based
on the slope of the entire linear-elastic region of the stress–strain curve.
In vitro cell culture
After sterilization, scaffolds were placed in 48 well plates and washed with PBS.
Each sample was seeded with 20µl media containing 75,000 Human Umbilical Vein
Endothelial Cells (HUVEC CC-2517, Lonza, Walkersville, MD) expanded to passage
4. After 24 hours, scaffolds were moved to 24 well plates and incubated in EGM-2
media (Lonza). All scaffolds were cultured in complete endothelial growth media
(EGM-2 media) with FBS, bFGF, VEGF, insulin-like growth factor (IGF), ascorbic
acid, epidermal growth factor (EGF), gentamycin sulfate and amphotericin-B (GA-
1000) and heparin (all from Lonza SingleQuots) at 37ºC, 5% CO2. Media were
replaced every 2 days for a total of 21 days. Scaffolds were harvested at different
experimental time points.
Proliferation
Cell number variations over time in culture were determined using a Picogreen DNA
quantification assay (Quant-iT PicoGreen dsDNA Assay Kit, Invitrogen, Grand
Island, NY). At pre-determined time points, medium was removed from wells and
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scaffolds washed three times with PBS. 500 μl of 0.05% Triton-X/PBS was used to
completely submerge the scaffold before freezing and storing at -20°C until analysis.
Each thawed sample was then sonicated for 10 s using a Virsonic ultrasonic cell
disrupter (Virtis, Warminster, PA). Samples (100 µl, in triplicate) were aliquoted
into a black 96 well plate and 100 μl PicoGreen working solution added to each
well. The plate was read on a Perkin Elmer HTS 7000 fluorescent plate reader
(excitation wavelength: 485 nm, emission wavelength: 535 nm). To calculate DNA
concentrations, a calibration curve was generated using the double stranded DNA
standard provided with the kit. Results were divided by 7.7 pg DNA, (the average
amount of DNA in a cell [175]), to obtain estimates of cell number.
Cell viability
The cellular metabolic activity was measured using the CellTiter Blue assay (Promega,
Madison, WI) which is based on the ability of living cells to reduce the non-
fluorescent compound resazurin to the fluorescent compound resorufin. The assay
was performed according to the manufacturer’s instructions. In brief, the seeded
scaffolds were incubated for 3 hours at 37°C with phenol red free culture medium
supplemented with Titer Blue diluted 1:5. The resulting fluorescence was read on a
fluorescence reader (excitation wavelength: 550 nm; emission wavelength: 595 nm).
Immunofluorescent localization of PECAM-1 expression on
endothelial cells
Cells were fixed with formaldehyde (4% w/v in PBS) for 15 min at room temper-
ature, washed with PBS and incubated in blocking buffer (6% BSA / 10% donkey
serum / PBS) for an hour. Subsequently the samples were incubated with primary
antibody against Platelet Endothelial Cell Adhesion Molecule (1:100, PECAM-1,
Santa Cruz Biotechnology, Inc., Santa Cruz, CA) overnight at 4°C. After washes in
PBS, the samples were incubated in secondary antibody (1:1000, donkey anti-rabbit
Alexa Fluor 568, Molecular Probes, Grand Island, NY) for 1.5 h at room tem-
perature. The scaffolds were washed again in PBS and permeabilized with 0.25%
Triton-X 100 in PBS for 20 min. This was followed by a brief rinse in PBS and a
nuclear counterstain (DAPI, Sigma Aldrich, St Louis, MO), according to the man-
ufacturer’s protocol. After the final rinses with PBS, samples were examined by
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confocal microscopy (Zeiss LSM 510 UV).
RNA isolation and reverse transcriptase–quantitative PCR
VWF (Von Willebrand Factor) and PECAM-1 genes were assessed by RT-qPCR
using a Custom PCR Array (RT2 Profiler PCR Array CAPH10845; SABiosciences,
Qiagen, Valencia, CA).
Total RNA from scaffolds (3 replicates for each group) was extracted using the
RNeasy MINI kit and QIAshredder columns (Qiagen) according to the manufac-
turer’s instructions. The total RNA was quantified using spectrophotometry (Nan-
odrop ND-1000,Thermo Scientific, Wilmington, DE) and ranged from 1.2 to 6 μg.
For best results on the PCR array, all RNA samples were selected for purity using an
A260/A280 UV spectrophotometry ratio greater than 1.99. 250 ng RNA was used
for cDNA synthesis, performed using the RT2 First Strand Kit (SABiosciences, Qia-
gen) according to the manufacturer’s protocol. The cDNA was then amplified using
RT2 qPCR Mastermix with RT2 Profiler PCR Arrays (SABiosciences, Qiagen). The
results were normalized to 3 housekeeping genes (HPRT1, GAPDH and RPL13A).
Relative gene expression values were analyzed using the RT2 Profiler PCR Array
Data Analysis version 3.5 web-based software package.
Subcutaneous implants, Microfil perfusion, and micro-CT
images
All animal procedures were approved by the Georgia Institute of Technology Institu-
tional Animal Care and Use Committee (IACUC # A10021). Female 9-10 week-old
Sprague Dawley rats (Charles River, Wilmington, MA) were housed two per cage
and had access to chow and water ad libitum. All scaffolds used for implantation
were prepared in a sterile biosafety cabinet and equilibrated in alpha MEM medium
(no additives) for 12 h. Each of 20 rats received four randomized dorsal subcuta-
neous implants. This was performed by making two lateral incisions on the dorsal
region and using a custom made tunneling tool to position the implant at a distance
from the incision site. After surgery the animals were given a single dose of 0.03
mg/kg buprenorphine for pain relief. In all instances, the implantation sites healed
without complications.
The vascular network in the scaffold area was investigated at 3 and 6 weeks post
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surgery using a modified version of a previously described micro CT-based angiog-
raphy technique [230]. After induction of anesthesia using 5% isoflurane, rats were
maintained at 2% isoflurane and the thoracic cavity was opened to insert an 18
gauge catheter (SURFLO ® Teflon IV catheter, Terumuo Medical) through the left
heart ventricle into the ascending aorta. The inferior vena cava was cut and 0.9%
saline was perfused through the vasculature using a peristaltic pump (Masterflex,
Cole-Parmer, Vernon Hills, IL) until complete clearance was achieved. Then 0.9%
saline containing 0.4% (w/v) papaverin hydrochloride was perfused. The rats were
then perfused with 10% neutral buffered formalin (NBF) for 5 minutes to fix the
vasculature. Then polymerizable, lead chromate-based, radiopaque contrast agent
(Microfil MV-122, Flow Tech, Carver, MA) was syringe-injected. The contrast agent
was prepared according to manufacturer instructions but diluted to 66 % (vol/vol)
with diluent and curing agent. Samples were stored at 4oC overnight to allow poly-
merization of the contrast agent before implant retrieval. Explants were rinsed in
PBS, immersion fixed in 10% neutral buffered formalin for 48h prior to imaging in
the Viva-CT system (Scanco Medical).
As previously described, isotropic slice data were obtained and reconstructed into
2D images. These slice images were compiled and analyzed to render 3D images
and obtain quantitative architectural parameters. Regions of interest were globally
thresholded based on X-ray attenuation and 3D images of the vascular network seg-
mented from the surrounding tissues. Harvested scaffolds were evaluated to quantify
the vessel volume, connectivity, number, thickness, and degree of anisotropy.
Histological analysis
Rats that were not perfusion fixed were euthanized by CO2 asphyxiation. Explants
(from perfused rats and fresh tissue) were immersion fixed in 10% NBF. The tissues
were processed and paraffin embedded for histological analysis. Sections, cut at 5
µm, were deparaffinized and rehydrated to stain with hematoxylin and eosin (H&E)
and imaged with brightfield microscopy to assess cellular organization. Represen-
tative sections were stained with 1% picrosirius red and observed under polarized
light to identify collagen fiber organization and maturation.
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Statistical analysis
The data are expressed as mean ± standard deviation (mean ± SD). Statistical
analyses were performed using Prism 5 (GraphPad, San Diego, CA). To determine
the statistical significance of the results one-way and two-way ANOVA tests were
performed (if the interaction term was significant). F-tests of the equality of the
variances were conducted with a significance level of 0.05. Significance was assigned
at p values less than 0.05. For RT-qPCR analysis, the RT2 Profiler PCR Array
Data Analysis version 3.5 web-based software package was used.
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5.4 Results
Scaffold morphology and mechanical properties
The two scaffold typologies were produced by the solvent casting particulate leach-
ing technique with or without silk fibroin fibers. NaCl concentration was adjusted
between the two groups to achieve the same porosity.
Figure 5.1: (A) From left to right: Scanning electron microscopy images, cross-
sectional micro-CT slices and color-coded pore diameter scale images of the two
scaffolds. (B) Porosity of the two scaffolds. (C) Pore size profile of the two
scaffolds. (D) Degree of anisotropy of the two scaffolds. Group 1: PdlLA salt-
leached sponge; Group 2: PdlLA salt-leached sponge with silk fibroin fibers.
Ultimately a concentration of 1:25 w/w polymer/porogen in group 1 (PdlLA) and
1:14 w/w polymer/porogen in group 2 (PdlLA + silk fibroin fibers) was considered
optimal. Resulting structures are shown in Fig. 5.1A.
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Figure 5.2: (A) Stress–strain plot of a representative compressive mechanical test-
ing for a PdlLA salt-leached sponge scaffold with linear fit slope shown. (B)
Elastic moduli of wet scaffolds after immersion in PBS for 30 min. *, p < 0.05.
Group 1: PdlLA salt-leached sponge; Group 2: PdlLA salt-leached sponge with
silk fibroin fibers.
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The analysis of the SEM images revealed that the fibers were randomly distributed
and well dispersed within the PdlLA sponge.
Micro-CT analysis generated slice information on the scaffolds and color graded
images of the pore size distribution. Reconstructed micro-CT 3D images provided a
quantitative morphometric analysis of the scaffolds. Accordingly, the porosity and
the pore size distribution were determined and are presented inFig. 5.1B and C. The
porosities were comparable in the two groups and in excess of 80%. Interestingly,
the pore size distribution was also similar and no big differences were observed in the
peaks or in the curve profiles of the two groups. Finally, scaffolds with silk fibroin
fibers (group 2) had significantly higher degree of anisotropy (Fig. 5.1D) compared to
group 1, indicating that group 2 is characterized by a preferential material direction.
Stresses and strains were plotted from the compression data.
Compressive moduli were calculated from the slope of the linear fit to the elastic
range of the stress-strain curve and the results (Fig. 5.2) demonstrate that the scaf-
folds with fibers have more than double the elastic modulus of the control scaffolds.
HUVECs proliferation, metabolic activity, distribution and
gene expression
7x104 HUVECs were seeded onto each scaffold and cultured in conditions promoting
angiogenesis. Retention and growth of endothelial cells were considered important
indications of scaffold properties.
The retention of cells on the two different scaffold groups was comparable (Fig. 5.3A,
day 1).
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Figure 5.3: (A) HUVEC cell number. *, p < 0.05. (B) Viability index for HUVEC
cell culture (normalized to cell number). $, p < 0.05 vs the same scaffold at
the previous time point. Group 1: PdlLA salt-leached sponge; Group 2: PdlLA
salt-leached sponge with silk fibroin fibers.
At day 7 there was a decrease in cell number which was probably due to a physio-
logical adaptation to the new environment and group 2 scaffolds were characterized
by a lower amount of cells. However, it appears that proliferation was favored in the
scaffold with silk fibroin fibers and at 21 days the number of cells was significantly
higher in that group.
Cell viability was determined during the cell culture period using the CellTiter-Blue
assay The metabolic activity (viability normalized to cell number) was comparable
in the cells seeded on the two different scaffolds at each time point (Fig. 5.3B). The
91
Chapter 5 Effects of silk fibroin fiber
profile was similar in the two groups: an increase in metabolic activity was observed
after day 1 with the peak at day 7.
Figure 5.4: RT-qPCR analysis of VWF and PECAM-1 gene expression in cells
seeded onto the scaffolds at different time points: (A), 7 days; (B), 21 days. No
significative differences are present (n=3). Group 1: PdlLA salt-leached sponge;
Group 2: PdlLA salt-leached sponge with silk fibroin fibers.
Reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) analyses
(Fig. 5.4) showed that the gene expression of the cells seeded onto the two different
scaffolds at 7 and 21 days was comparable, based on VWF and PECAM-1 mRNA
levels. No significant differences in gene expression were observed between the two
scaffold groups at either the 7 or 21 day timepoints.
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Figure 5.5: Confocal Laser Scanning Microscopy images of HUVEC cells stained
for nuclei (DAPI, blue) and PECAM-1 (red). Group 1 and Group 2 at 7, 14 and
21 days after cell seeding are shown. Silk fibroin fibers stain with DAPI. Scale bars
= 100 µm. Group 1: PdlLA salt-leached sponge; Group 2: PdlLA salt-leached
sponge with silk fibroin fibers.
Confocal microscopy and immunolocalization were used to evaluate cell distribution
and PECAM-1 protein expression at cell-cell junctions (Fig. 5.5). Cells attached to
both scaffolds. In group 1, cells did not express a strong PECAM-1 signal, and after
21 days it was only present around pore edges. In group 2, cells seemed to prefer
to attach to the fibers, then, as their number increased, they colonized not only
the fibers but the spaces in between. PECAM-1 expression appeared qualitatively
higher with increasing days in culture in scaffolds with silk fibroin fibers.
Subcutaneous model, histology and perfusion
Rats were perfused with a vascular contrast agent to quantify blood vessel ingrowth
3 or 6 weeks after acellular construct implantation. Examination of the explanted
samples revealed that scaffolds became vascularized and that scaffold materials were
93
Chapter 5 Effects of silk fibroin fiber
not completely degraded.
The subcutaneous implants were stained with hematoxylin and eosin (Fig. 5.6A) to
show nuclei and possible cellular infiltration.
Figure 5.6: Histological images of sections (5 μm) of explanted scaffolds. Left
pictures (A) show samples stained with hematoxylin and eosin at 3 and 6 weeks
with sample at 3 weeks perfused with vascular contrast agent. Black arrows
indicate multinucleated giant cells. Right pictures (B) show samples stained with
picrosirius red at 3 weeks. Center area indicates an inner part of the implants,
edge area the interface between the implants and newly formed tissue. Scale bars
= 100 µm. Vascular contrast agent is also seen in the center area images in B.
Group 1: PdlLA salt-leached sponge; Group 2: PdlLA salt-leached sponge with
silk fibroin fibers.
Histological analyses showed tissue ingrowth into both the scaffolds. Moreover mult-
inucleated giant cells (macrophages) were visible at the interface between new tissue
and the material especially in group 2 at 3 weeks. A comparison of group 1 with
group 2 after 3 weeks of culture shows that qualitatively more blood vessels are
present in the scaffold with silk fibroin fibers, as evidenced by black spots of per-
fused contrast agent.
The organization of newly formed collagen matrix was evaluated using picrosirius
red staining and polarized light microscopy. In both groups a fibrous capsule formed
around the implanted scaffold. The capsule did not block tissue ingrowth into the
scaffolds and collagen (birefringent yellow/orange fibers) was partially oriented and
aligned in each group.
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Figure 5.7: (A) Micro-CT images of scaffold implanted subcutaneously in rat per-
fused with Microfil vascular contrast agent. Vasculature (dark grey) growing into
implant area (light grey), (B) Quantification of vascular volume/total scaffold vol-
ume. *, p< 0.05 (C) Representative scans of blood vessels 3 and 6 weeks after
implantation. Color scale bars, defining vessel diameters, range from 0 to 320
µm at 3 weeks to 0 to 240 µm at 6 weeks. Group 1: PdlLA salt-leached sponge;
Group 2: PdlLA salt-leached sponge with silk fibroin fibers.
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Perfused scaffolds were carefully harvested, cleaning them from the surrounded tissue
to restrict evaluation to the vessels inside the scaffold. Fig. 5.7A shows the vessels
(dark gray) which have invaded the scaffold area (light gray). Micro-CT analysis
revealed a significantly greater vessel volume normalized to scaffold volume in group
2 compared to group 1 at 3 weeks (Fig. 5.7B). At 6 weeks, the vascular volume
was comparable in the two groups. In Figure 7C representative scans of perfused
constructs of both groups at 3 and 6 weeks after implantation are shown. The
diameters of the vessels are displayed on a color scale. As before, there is a greater
vascular volume in group 2 at 3 weeks, whereas there is no difference between the
groups at 6 weeks.
Finally other morphological parameters such as connectivity, vessel number, and
degree of anisotropy were evaluated. The measure of the interconnectedness of the
vascular structures (Fig. 5.8A) and the number of distinct vessels (Fig. 5.8B) were
not significantly altered by the presence of silk fibroin fibers. However the addition
of silk fibroin fibers favored a higher degree of anisotropy, indicating a preferential
orientation of the vessels (Fig. 5.8C).
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5.5 Discussion
Rapid and sufficient integration of implants with the host vasculature, to ensure
an adequate supply of oxygen and nutrients, remains a significant challenge in tis-
sue engineering. This study demonstrates that modification of a baseline scaffold
resulted in improved mechanical properties and accelerated tissue integration and
vascularization in vivo.
First we demonstrate the ability to generate two different constructs (PdlLA alone
or PdlLA with silk fibroin fibers), such that stiffness was increased upon addition of
fibers but porosity remained the same. The compression testing results show that
the scaffolds with fibers are two-fold stiffer than the PdlLA alone. The increase
in apparent elastic modulus achieved in scaffolds with the fibroin fibers could be
attributed to their structure, in which triaxial stresses that are established dur-
ing compression, are also relatively high in tension. Therefore, the addition of an
oriented structure, such as the fibroin fibers, could provide benefits in terms of me-
chanical properties even if positioned randomly or longitudinally to the applied load,
as demonstrated in a reticular structure [231].
In culture, we showed that cell proliferation at 21 days was higher for group 2,
probably due to the active domains of silk fibroin. In fact, fibroin protein peptides
have been demonstrated to enhance cell growth [132]. We also showed that, even
if gene expression was unaffected, the adhesion molecule PECAM-1, a well-known
endothelial marker, was much more extensively located on the membrane of cells
seeded onto the scaffolds with silk fibroin fibers. One explanation may have been
related to the amino acid sequences of the fibroin molecule that have been shown
to support endothelial cell phenotype and activity [211, 232]. Furthermore, it has
to be considered that the gene expression results were normalized to housekeeping
genes and, for this reason, the higher cell number of HUVECs supported by the
group 2 scaffolds at day 21 would partially explain the more PECAM-1 observed as
the cells are more crowded. The immunolocalization of PECAM-1 mechanoreceptor
to the cell-cell junction at 21 days suggests a higher degree of organization of the
endothelial cells in group 2, proving that scaffold with silk fibroin fibers better
support endothelial cells in static culture.
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Figure 5.8: (A) Vascular connectivity, (B) Number of vessels and (C) Degree of
anisotropy of scaffolds at 3 and 6 weeks after implantation.*, p< 0.05. Group 1:
PdlLA salt-leached sponge; Group 2: PdlLA salt-leached sponge with silk fibroin
fibers.
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The vascularization of the scaffolds in vivo is of great importance for understand-
ing the possible applications of this material. Recent studies have underscored how
differences in the inflammatory response can lead to differences in tissue repair.
Macrophages and multinucleated giant cells play a major role in scaffold vascular-
ization by virtue of their secretion of pro-angiogenic factors [70, 182, 202].
In our study, it is evident that the implantation of both scaffolds caused an inflam-
matory response, highlighted by the fibrotic capsule encircling all the scaffolds and
by the presence of giant multinucleated cells (even more prominent in the scaffolds
with silk fibroin fibers). It is a fair assumption that the silk fibroin fibers interacted
with macrophages and multinucleated giant cells in order to accelerate the vascu-
larization process at 3 weeks. However, the in vivo perfusion results show that a
fully integrated host vasculature formed in the acellular scaffolds of both groups,
indicating an earlier and faster integration of scaffolds from group 2.
The other significant parameter different in the two groups is related to vessel
anisotropy. In the scaffold with silk fibroin fibers, vessels had a preferred direc-
tion in agreement with the scaffold anisotropy. It seems that, even if the fibers had
been randomly distributed, the general structure in group 2 shows some level of
organization, guiding the orientation of the vessel formation.
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5.6 Conclusions
This study demonstrated that adding silk fibroin fibers to a PdlLA salt-leached
sponge increased scaffold stiffness, and heightened its capacity to support endothelial
cells in vitro and to promote vascularization in vivo. The immunolocalization of
PECAM-1 mechanoreceptor to the cell-cell junction at 21 days suggests that scaffold
with silk fibroin fibers better support endothelial cells in static culture. Additionally
the in vivo perfusion results indicate that a fully integrated host vasculature formed
in the acellular scaffolds of both groups, with faster vascularization of the composite
scaffolds. Further studies using segmental bone defect models and considering both
vascularization and mineralization are warranted to better characterize the role of
silk fibroin fibers added to a PdlLA scaffold in the bone healing process.
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6 Human Mesenchymal Stem
Cells Seeded onto PdlLA
Scaffolds: Influence of Addition
of Silk Fibroin Fiber and
Endothelial Cells
6.1 Abstract
This study investigated the influence of silk fibroin fiber incorporation into a porous
salt–leached Poly D, L-Lactic Acid (PdlLA) scaffold on its support of human mes-
enchymal stem cell (hMSC) and human umbilical vein endothelial cell (HUVEC)
cultures. hMSCs alone and in combination with HUVECs were seeded onto PdlLA
scaffolds with and without silk fibroin fibers and maintained in osteogenic medium
for up to six weeks in vitro. Cell behavior was investigated using indices such as cell
viability, proliferation, and alkaline phosphatase activity for a range of time points
and harvested scaffolds underwent PECAM-1 and Collagen I immunolocalization
and real time RT-PCR analysis for osteogenic and angiogenic gene expression. Our
findings suggest that, despite similar porosities exhibited by the PdlLA and PdlLA
plus fibroin scaffolds, there were marked differences in cell distribution and function.
Endothelial cell localization was strongly associated with fiber presence yet, in the
absence of fibers, an early osteogenic differentiation of mesenchymal stem cells was
observed in the scaffolds. This study attests the influence of silk-fibroin fibers on
the biological attributes of PdlLA salt leached scaffolds and provides information
on the inter-relationship between endothelial cells and hMSCs cultured in these en-
vironments. The concept of designing composite scaffolds to integrate beneficial
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properties of various structures and materials to facilitate appropriate biological
responses would seem a promising avenue of research.
6.2 Introduction
Tissue engineering research shows great promise for the treatment of bone defects
and fracture non-union. While scaffolds of increasing complexity have been created,
the roles of endogenous precursor cells in the vascularization and mineralization
processes remain unclear.Osteogenesis is a complex process that involves the well-
orchestrated interaction of various cell types [233, 234]. The processes integral to
bone formation are thought to be dependent on angiogenesis due to the close interac-
tion between the bone-forming osteoblasts (OBs) and the vessel-forming endothelial
cells (ECs) [220, 235, 236, 237].
Several in vitro studies have investigated the interaction between OBs and ECs using
co-culture systems as tools for mimicking the complex structures and regulation
processes of living tissue[232]. It was demonstrated that direct contact between
OBs and ECs is necessary for establishment of a suitable model for studying the
interaction between these two cell types, as both direct cell contact and paracrine
mechanisms should be considered [235, 236, 238, 239].
The nature of this argument is complex due to the use of different osteoblast cell
lines and endothelial cell types [182] which often leads to contradictory results.
Nevertheless studies in vitro have shown that endothelial cells regulate the function
of osteoblast cells and vice versa [240, 241, 242].
While most authors found that endothelial cells had a positive effect on osteoblast
proliferation [240, 242] their influence on osteoblast differentiation was somewhat
more controversial [242, 243, 244]. Perhaps of equal importance is the interaction
of the bone marrow derived stromal cells with endothelial cells, since these can give
rise to osteoblastic precursor cells.
Here we examine the influence of endothelial cells and silk fibroin fibers on the differ-
entiation of MSCs cultured on PDLLA scaffolds in osteogenic culture conditions. To
our knowledge, this is the first study to investigate cultures of bone marrow-derived
mesenchymal stem cells and endothelial cells on a silk fibroin enhanced PDLLA scaf-
fold. We tested hMSC and hMSC plus HUVECs for the ability to support osteogenic
differentiation and development of vascular structures with the goal being to ascer-
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tain the influence of endothelial cells and silk fibroin fibers on tissue formation in
the scaffolds.
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6.3 Materials and Methods
Scaffold production
Two experimental groups were established; Group 1 (PDLLA scaffold only) and
Group 2 (PDLLA scaffold with fibroin fibers).
Group 1 was produced by the solvent casting particulate leaching technique. PDLLA
(Resomer R207S, Boehringer Ingelheim, Germany) was dissolved in dichloromethane:dimethylformamide
(70:30 v/v) and a 7% (w/v) solution was prepared. Sieved NaCl particulates, rang-
ing from 425 to 1180 µm, were mixed with PDLLA, obtaining a 1:25 w/w poly-
mer/porogen final concentration. The mixture was air dried (24-36 hours) and
immersed in deionized water (dH2O) for 3 days with changes every 6 hours for the
removal of the porogen.
Fibers were introduced into the scaffold (Group 2) as described previously [245].
Briefly, the Bombyx mori silkworm cocoons were degummed in order to remove
sericin. Degummed silk fibers were then washed several times in distilled water and
dried at room temperature. Then 0.05 g of these spread fibers was mixed with sieved
NaCl particulates, ranging from 425 to 1180 µm as in Group 1, and the PDLLA
solution (as above), obtaining a 1:14 w/w polymer/porogen final concentration. The
mixture was air dried (24-36 hours) and immersed in deionized water (dH2O) for 3
days with changes every 6 hours for the removal of the porogen. Before use, scaffolds
were cut into discs of 8 mm diameter, sterilized with aqueous ethanol solution 70%
(v/v) and dried under a sterile hood at room temperature.
In vitro cell culture
After sterilization, scaffolds were placed in 48 well plates and washed with PBS. Each
sample was seeded with 10µl media containing 75,000 Human Mesenchymal Stem
Cells (Prockop Laboratory, Texas A&M University, Texas) expanded to passage 3
(not allowed to expand beyond 80% confluency) or 75,000 hMSC plus 75,000 Hu-
man Umbilical Vein Endothelial Cells (HUVEC CC-2517, Lonza, Walkersville, MD)
expanded to passage 4. After 24 hours, scaffolds were moved to 24 well plates and
incubated in MEM alpha medium (Invitrogen). All scaffolds were cultured in MEM
alpha medium with 16% (v/v) fetal bovine serum (FBS, Atlanta Biologicals), 100
U Penicillin,100 µg Streptomycin, 2 mM L-glutamine (Invitrogen), 6 mM β-glycerol
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phosphate (Sigma), 50 µg/mL ascorbic acid 2-phosphate (Sigma), 1 nM dexametha-
sone (Sigma) and 50 ng/mL L-thyroxine (Sigma) at 37ºC, 5% CO2. Media were
replaced every 48 hours for a total of 42 days. Scaffolds were harvested at different
experimental time points.
Proliferation
Cell number over time in culture was determined using a Picogreen DNA quan-
tification assay (Quant-iT PicoGreen dsDNA Assay Kit, Invitrogen, Grand Island,
NY). At pre-determined time points, medium was removed from wells and scaffolds
washed three times with PBS. 500 μl of 0.05% Triton-X/PBS was used to com-
pletely submerge the scaffold before freezing and storing at -20°C until analysis.
Each thawed sample was then sonicated for 10 s using a Virsonic ultrasonic cell
disrupter (Virtis, Warminster, PA) and centrifuged. Samples (100 µl, in triplicate)
were aliquoted into a black 96 well plate and 100 μl PicoGreen working solution
added to each well. After 5 minutes the plate was read on a Perkin Elmer HTS 7000
fluorescent plate reader (excitation wavelength: 485 nm, emission wavelength: 535
nm). To calculate DNA concentrations, a calibration curve was generated using the
double stranded DNA standard provided with the kit. Results were divided by 7.7
pg DNA, (the average amount of DNA in a cell [175]), to obtain estimates of cell
number.
Cell viability
The cellular metabolic activity was measured using the CellTiter Blue assay (Promega,
Madison, WI) which is based on the ability of living cells to reduce the non-
fluorescent compound resazurin to the fluorescent compound resorufin. The assay
was performed according to the manufacturer’s instructions. Briefly, the seeded
scaffolds were incubated for 3 hours at 37°C with phenol red free culture medium
supplemented with Titer Blue diluted 1:5. The resulting fluorescence was read on a
fluorescence reader (excitation wavelength: 550 nm; emission wavelength: 595 nm).
ALP activity
The concentration of alkaline phosphatase (ALP) was determined, using the lysates
used for DNA quantification. Briefly, the ALP activity of the cells was assessed
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by measuring the release of p-nitrophenol (yellow salt) from p-nitrophenyl phos-
phate. Standards were prepared with a 10mM p-nitrophenol solution, to obtain
a standard curve. The color change was measured spectrophotometrically at 405
nm. The amounts of resulting p-nitrophenol released by the cells were quantified by
comparison with the standard curve and normalized to the total ng of DNA.
Immunofluorescent localization of PECAM-1 and Collagen I
expression
Cells were fixed with formaldehyde (4% w/v in PBS) for 15 min at room temper-
ature, washed with PBS and incubated in blocking buffer (6% BSA / 10% donkey
serum / PBS) for an hour. Subsequently the samples were incubated with 1o anti-
body against Platelet Endothelial Cell Adhesion Molecule (1:100, PECAM-1, Santa
Cruz Biotechnology, Inc., Santa Cruz, CA) or human type I collagen (1:100, Merid-
ian Life Science, Saco, ME, USA) overnight at 4°C. After washes in PBS, the samples
were incubated in 2o antibody (1:1000, donkey anti-rabbit Alexa Fluor 568, Molec-
ular Probes, Grand Island, NY) for 1.5 h at room temperature. The scaffolds were
washed again in PBS and permeabilized with 0.25% Triton-X 100 in PBS for 20
min. This was followed by a brief rinse in PBS and a nuclear counterstain (DAPI,
Sigma Aldrich, St Louis, MO), according to the manufacturer’s protocol. After the
final rinses with PBS, samples were examined by confocal microscopy (Zeiss LSM
510 UV).
RNA isolation and reverse transcriptase–quantitative PCR
ALP (Alkaline phosphatase), COL1A1 (Collagen, type I, alpha 1), RUNX2 (Runt-
related transcription factor 2), OC (Osteocalcin), VWF (Von Willebrand Factor)
and PECAM-1 gene expression were assessed by RT-qPCR using a Custom PCR
Array (RT2 Profiler PCR Array CAPH10845; SA Biosciences, Qiagen, Valencia,
CA).
Total RNA from scaffolds (3 replicates for each group) was extracted using the
RNeasy MINI kit and QIAshredder columns (Qiagen) according to the manufac-
turer’s instructions. The total RNA was quantified using spectrophotometry (Nan-
odrop ND-1000,Thermo Scientific, Wilmington, DE) and ranged from 2.8 to 7.5 μg.
For best results on the PCR array, all RNA samples were selected for purity using a
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A260/A280 UV spectrophotometry ratio ≥ 2.00. 250 ng RNA was used for cDNA
synthesis, performed using the RT2 First Strand Kit (SA Biosciences, Qiagen) ac-
cording to the manufacturer’s protocol. The cDNA was then amplified using RT2
qPCR Mastermix with RT2 Profiler PCR Arrays (SA Biosciences, Qiagen). The
results were normalized to 3 housekeeping genes (HPRT1, GAPDH and RPL13A).
Relative gene expression values were analyzed using the RT2 Profiler PCR Array
Data Analysis version 3.5 web-based software package.
Micro-CT mineralization analysis
At 3, 4, 5 and 6 weeks, samples were aseptically removed from culture and placed in
custom tubes for Micro-CT scanning. Mineralized matrix was determined by using
a Viva-CT scanner (Scanco Medical, Bassersdorf, Switzerland) at 55 kVp and 200
ms integration time. The isotropic slice data were obtained and reconstructed into
2D images. These slice images were compiled and analyzed to render 3D images.
Regions of interest were globally thresholded based on X-ray attenuation (threshold
of 65 with a filter width of 1.0 and a filter support of 0.5). The total volume of the
mineralized matrix was thus determined.
Histological analysis
Samples were fixed in 10% NBF. The tissues were processed and paraffin embedded
for histological analysis. Sections, cut at 5 µm, were deparaffinized and rehydrated
to stain with von Kossa to quantify mineralization (phosphate deposition).
Statistical analysis
The data are expressed as mean ± standard deviation (mean ± SD). Statistical
analyses were performed using Prism 5 (GraphPad, San Diego, CA). To determine
the statistical significance of the results one-way and two-way ANOVA tests were
performed (if the interaction term was significant). F-tests of the equality of the
variances were conducted with a significance level of 0.05. Significance was assigned
at p values less than 0.05. For RT-qPCR analysis, the RT2 Profiler PCR Array
Data Analysis version 3.5 web-based software package was used.
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6.4 Results and Discussions
Previous studies using scanning electron microscopy and mechanical testing evalu-
ated scaffold morphologies and the compressive modulus, respectively [245].
In this study hMSCs or hMSCs plus HUVECs were seeded onto each scaffold and
cultured in conditions promoting osteogenesis for six weeks.
Figure 6.1: Cell number normalized for the number of cells at day 1. *, p< 0.05 vs
the Group1 (hMSC): #, p< 0.05 vs the Group1 (hMSC+HUVEC); @, p< 0.05
vs the Group2 (hMSC). Group 1: PdlLA salt-leached sponge; Group 2: PdlLA
salt-leached sponge with silk fibroin fibers.
Cell proliferation was evaluated for the first 21 days, normalizing the cell number at
given time points by the number of cells at day 1. In Fig. 6.1 the cell number profile
is shown. Scaffolds seeded with hMSC show an increase in cell number, especially
in Group 1. The number of cells in scaffolds co-cultured with hMSC and HUVECs
does not vary with time and in Group 2 it decreases. Group 1 and 2 seeded with
hMSCs and HUVECs start with double the number of cells.
The metabolic activity (viability normalized to the cell number) was determined
during the cell culture period using the CellTiter-Blue assay (Fig. 6.2). The profile
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was comparable during the culture except for Group 1 (with hMSC) at day 1,
showing a much higher value.
Figure 6.2: Viability index for cell culture (viability normalized to cell number).
*, p< 0.05 vs the Group1 (hMSC): #, p< 0.05 vs the Group1 (hMSC+HUVEC);
@, p< 0.05 vs the Group2 (hMSC). Group 1: PdlLA salt-leached sponge; Group
2: PdlLA salt-leached sponge with silk fibroin fibers.
The confocal laser microscopy images of Alexa 568 and DAPI to visualize type I
collagen organization and nuclei (Fig. 6.3) showed that at day 7 in each of the four
samples organized fibers were present. At day 21 collagen type I fibers seemed
packed and aligned. However, in Group 2 seeded with hMSCs and HUVECs, type
I collagen was not detectable.
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Figure 6.3: Confocal Laser Scanning Microscopy images of the samples stained
with a specific antibody for collagen I. Images of 7 and 21 days after cell seeding
are reported. Group 1: PdlLA salt-leached sponge; Group 2: PdlLA salt-leached
sponge with silk fibroin fibers. Scale bars = 100 µm.
110
6.4 Results and Discussions
ALP is one of the first functional genes expressed in the process of mineralization
and for many, it has become the marker of choice when assessing the phenotype
or developmental maturity of cells undergoing osteogenic differentiation. For these
reasons the ALP activity of the cells on the scaffolds was measured (Fig. 6.4). In
the cells seeded onto Group 1 (with hMSC or with hMSC and HUVECs) the ALP
activity was higher, especially at day 21.
Figure 6.4: ALP activity. *, p< 0.05 vs the Group1 (hMSC): #, p< 0.05 vs the
Group1 (hMSC+HUVEC); @, p< 0.05 vs the Group2 (hMSC). Group 1: PdlLA
salt-leached sponge; Group 2: PdlLA salt-leached sponge with silk fibroin fibers.
Reverse transcriptase–quantitative PCR was used to verify if at 21 days„ there were
differences in the gene expression profiles of cultures on Group 1 scaffolds (Fig. 6.5).
Expectedly PECAM and VWF, two typical endothelial markers, were up regulated
in the scaffolds with the co-culture but, surprisingly, ALP was up-regulated in the
same samples.
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Figure 6.5: Volcano plot with significant gene expression changes between Group
1 scaffolds seeded with hMSCs and Group 1 scaffolds seeded with hMSC and
HUVECs. Group 1: PdlLA salt-leached sponge.
Micro-CT was used to measure the total mineralized tissue volume (Fig. 6.6). The
results showed that, until week 4, no appreciable mineral deposition was apparent.
At week 5 there was an increase especially for Group 1 and at week 6 the higher
deposition of mineral was obtained for Group 1 seeded with hMSC and HUVECs.
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Figure 6.6: (A) Quantification of the mineralization. *, p< 0.05 vs the Group1
(hMSC): #, p< 0.05 vs the Group1 (hMSC+HUVEC); @, p< 0.05 vs the Group2
(hMSC). Group 1: PdlLA salt-leached sponge; Group 2: PdlLA salt-leached
sponge with silk fibroin fibers. (B) Micro-CT images of mineralized scaffolds
after 6 weeks of cell culture.
To confirm micro-CT results, histology sections were stained with von Kossa. This
113
Chapter 6 Effects of silk fibroin fiber and endothelial cells
reveals phosphate deposition (Fig. 6.7). The images showed (need to orientate people
as to where its from) that the phosphate deposition was only detectable in samples
from Group 1.
Figure 6.7: Histological images of sections (5 μm) of scaffolds. Samples were
stained with von Kossa at 6 weeks. Arrows show granular microdeposits of phos-
phate. Group 1: PdlLA salt-leached sponge; Group 2: PdlLA salt-leached sponge
with silk fibroin fibers. Scale bars = 100 µm.
Reverse transcriptase–quantitative PCR was also used to compare the gene profiles
of cells on different scaffolds. Interestingly, the gene expression of the cells in co-
cultures seeded on Group 2 scaffolds compared to Group 1 (Fig. 6.8) showed that at
day 21, Group 2 endothelial markers (VWF and PECAM) were up-regulated.
This result was confirmed qualitatively by confocal laser microscopy images (Fig. 6.9).
In this case we used a specific antibody against PECAM-1. This membrane protein
was not detectable in either scaffold at day 21 and at day 7 it was visible only in
Group 2.
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Figure 6.8: Volcano plot with significant gene expression changes between Group
1 scaffolds seeded with hMSCs and HUVECs and Group 2 scaffolds seeded with
hMSC and HUVECs. Group 1: PdlLA salt-leached sponge; Group 2: PdlLA
salt-leached sponge with silk fibroin fibers.
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6.5 Conclusions
The PdlLA scaffolds favor the proliferation of seeded hMSC while the same scaf-
folds seeded with the co-culture indicate enhanced differentiationby their increased
amount of mineralized tissue. With addition of silk fibroin fibers to the scaffold,
hMSC differentiation appears inhibited or at least delayed , despite the presence
of aligned ECM. Conversely, the same scaffolds support HUVECs in co-cultures, at
least at early time points where it was possible to notice a certain degree of organiza-
tion (Figure 9 with PECAM staining) despite use of osteogenic culture conditions. It
is possible that the hMSC differentiated into endothelial cells (alternative source for
tissue replacement/vascularisation, Oswald Stem Cells 22:3: 377-384, 2004). These
results are of interest because they demonstrate how the addition of endothelial cells
can affect hMSC phenotype and that such modifications can be modulated by scaf-
fold composition and structure. In the present study, the introduction of silk fibroin
fibers to a PdlLA sponge affected both angiogenesis and osteogenesis, modulating
phenotypes of hMSCs and HUVECs. In the future such studies could be extended
to a small animal defect model to determine if scaffold composition and co-cultures
perform similarly in vivo. If applicable to the bone defect, modulation of the scaffold
and cell types could determine whether promotion of angiogenesis or mineralization
processes could accelerate the healing process.
Figure 6.9: Confocal Laser Scanning Microscopy images of cells stained for nuclei
(DAPI, blue) and PECAM-1 (red). Group 1 and Group 2 at 7 days after cell
seeding are shown. Group 1: PdlLA salt-leached sponge; Group 2: PdlLA salt-
leached sponge with silk fibroin fibers. Scale bars = 100 µm.
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The overall objective of this thesis was to design and evaluate, using different strate-
gies, a novel functional scaffold for a bone tissue engineering application.
The general idea was to mimic the natural ECM. The mature bone is widely consid-
ered the ‘golden standard’ for bone tissue engineering scaffold model. Differently, in
all this research work, we move our attention from the final stage of bone healing to
an earlier stage, considering the bony callus. It is a temporary tissue, characterized
by a collagen network, template for the subsequent healing process that terminates
with the mineralized matrix.
We modulated scaffold (made of PdlLA or/and SF) parameters and we correlate
them with collagen production and assembling, evaluating which favour ECM min-
eralization.
In a first approach, we compared scaffolds with ordered and random geometries,
produced by a microfabrication system and by solvent casting particulate leaching
techniques respectively. The results showed that, even if cells growing and prolifera-
tion were comparable, the collagen production and its organization on the scaffolds
with a randomly distributed porosity seemed to be more suitable for a bone tissue
regeneration application.
We subsequently demonstrated the important role of pore size on cell behaviour and
in particular on ECM production and organization.
Once selected a proper pore size and scaffold geometry, we improved the capacity of
constructs to be vascularised, introducing SF fibers to the PdlLA sponges for their
structural and biological properties.
Finally, working on scaffold structure and composition, we were able to trigger the
response of co-cultured cells, influencing and favouring angiogenesis or osteogenesis.
In all the described steps, we put a lot of effort in characterizing the ECM matrix
production and organization, finding that evaluation of type I collagen assembling
could be considered a useful tool to predict the degree of the final mineralization as
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regards the regenerative process.
This work results interesting and innovative because it emphasizes the possibility
to correlate the scaffold morphology to type I collagen assembly, which in turn
affects the final mineralization process, allowing to evaluate the tissue produced by
osteoblasts from the first steps in bone formation. Moreover, we were able to trigger
and control some cell behaviours changing construct characteristics.
Further research is required to deeply study the strict relation between type I col-
lagen and mineralization. Additionally, a segmental bone defect models should be
considered to characterize the role of silk fibroin fibers during the bone healing pro-
cess and to determine whether there is correspondence between the results and our
in vitro model outcomes.
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